Marketing Authorisation 69689 for MedicinalProductDefinition 901491e0-66cc-4f9e-9614-52cb311d0731

Metformin axapharm Filmtabl 500 mg Blist 50 Stk

Metformin axapharm Filmtabl 500 mg Blist 100 Stk

Marketing Authorisation 69689001-c6bcd298-7998-406c-8e05-c09d8b985a9d for PackagedProductDefinition c6bcd298-7998-406c-8e05-c09d8b985a9d

Marketing Authorisation 69689002-d2c6bec7-8aec-4cca-a00f-9136afa31a73 for PackagedProductDefinition d2c6bec7-8aec-4cca-a00f-9136afa31a73

Reimbursement SL 2add99da-79ed-4766-84f0-ea0e12985667 for PackagedProductDefinition c6bcd298-7998-406c-8e05-c09d8b985a9d

Reimbursement SL 05b7a2b6-9cf9-464d-b9aa-70a15c48843b for PackagedProductDefinition d2c6bec7-8aec-4cca-a00f-9136afa31a73

Metformini hydrochloridum


07.06.20. Orale blutzuckersenkende Mittel

Metformine axapharm cpr pell 500 mg (ancien)

Marketing Authorisation 59099 for MedicinalProductDefinition 36170cd0-92b0-407c-b0fb-0614bf6c8122

Metformin axapharm Filmtabl 500 mg (alt) 50 Stk

Medicinal product subject to medical or veterinary prescription (B)

Metformin axapharm Filmtabl 500 mg (alt) 100 Stk

Marketing Authorisation 59099011-864a89c6-ae08-48fe-b6c9-0def0d8fbfb5 for PackagedProductDefinition 864a89c6-ae08-48fe-b6c9-0def0d8fbfb5

Marketing Authorisation 59099014-a96c934a-dfa9-4d65-b546-153b2aa75127 for PackagedProductDefinition a96c934a-dfa9-4d65-b546-153b2aa75127

Reimbursement SL cfc28232-b1d0-40c2-99c4-4d729f13e1a4 for PackagedProductDefinition 864a89c6-ae08-48fe-b6c9-0def0d8fbfb5

Price mutation after triennal review of pharmaceuticals

Reimbursement SL 0182910d-b510-4c11-adb6-653faa7d715f for PackagedProductDefinition a96c934a-dfa9-4d65-b546-153b2aa75127

Metformini hydrochloridum


Marketing Authorisation 69689 for MedicinalProductDefinition 3347d810-2b75-48e6-9746-ba0c4ddfb470

Metformin axapharm Filmtabl 850 mg Blist 30 Stk

Metformin axapharm Filmtabl 850 mg Blist 100 Stk

Marketing Authorisation 69689003-088df232-9ab0-4423-889c-f7e16d9d2d04 for PackagedProductDefinition 088df232-9ab0-4423-889c-f7e16d9d2d04

Marketing Authorisation 69689004-e9ff50b7-173d-4747-a282-1048a022b98f for PackagedProductDefinition e9ff50b7-173d-4747-a282-1048a022b98f

Reimbursement SL 68b44f8d-f6e5-4a90-9dd2-e33eee85a968 for PackagedProductDefinition 088df232-9ab0-4423-889c-f7e16d9d2d04

Reimbursement SL e852c1b2-74a6-4542-8093-24e2edf7a507 for PackagedProductDefinition e9ff50b7-173d-4747-a282-1048a022b98f

Metformini hydrochloridum


Metformine axapharm cpr pell 850 mg (ancien)

Marketing Authorisation 59099 for MedicinalProductDefinition acf7a29d-09fe-4e25-8c40-3423df5d58db

Metformin axapharm Filmtabl 850 mg (alt) 30 Stk

Metformin axapharm Filmtabl 850 mg (alt) 100 Stk

Marketing Authorisation 59099012-4b5d5dc7-ed2f-4fc9-a195-b58b9656e40b for PackagedProductDefinition 4b5d5dc7-ed2f-4fc9-a195-b58b9656e40b

Reimbursement SL 8097da02-8e71-43e7-bffb-647fcc9124d0 for PackagedProductDefinition 4b5d5dc7-ed2f-4fc9-a195-b58b9656e40b

Reimbursement SL ca8ca649-fa35-4862-b959-31e075f22942 for PackagedProductDefinition 4c728346-7052-40e5-bb06-3b65e39819a0

Metformini hydrochloridum


Marketing Authorisation 69689 for MedicinalProductDefinition c911fb0a-4b93-43b2-aead-bc9dd8aadf1b

Metformin axapharm Filmtabl 1000 mg Blist 60 Stk

Metformin axapharm Filmtabl 1000 mg Blist 120 Stk

Marketing Authorisation 69689005-88a3fdcd-bf55-41cb-aa1c-2a44aca350ce for PackagedProductDefinition 88a3fdcd-bf55-41cb-aa1c-2a44aca350ce

Marketing Authorisation 69689006-8f50c199-1ac2-4f90-a2fe-0e29666162a4 for PackagedProductDefinition 8f50c199-1ac2-4f90-a2fe-0e29666162a4

Reimbursement SL 51dbc8f4-a9b8-473d-838a-b933294d14d0 for PackagedProductDefinition 88a3fdcd-bf55-41cb-aa1c-2a44aca350ce

Reimbursement SL bb7f2045-c168-46f8-bdcb-9ba18471bd18 for PackagedProductDefinition 8f50c199-1ac2-4f90-a2fe-0e29666162a4

Metformini hydrochloridum


Metformine axapharm cpr pell 1000 mg (ancien)

Marketing Authorisation 59099 for MedicinalProductDefinition 77d78f0b-3090-41e5-b8c2-815a794bc01a

Metformin axapharm Filmtabl 1000 mg (alt) 60 Stk

Metformin axapharm Filmtabl 1000 mg (alt) 120 Stk

Marketing Authorisation 59099008-6df71dad-62e2-4ed1-8715-da4e090aad58 for PackagedProductDefinition 6df71dad-62e2-4ed1-8715-da4e090aad58

Marketing Authorisation 59099010-b74525af-fd3c-4ce6-aaec-5a2b7e5e581a for PackagedProductDefinition b74525af-fd3c-4ce6-aaec-5a2b7e5e581a

Reimbursement SL 87135b9c-a70e-4cce-bb81-c108bc3461ec for PackagedProductDefinition 6df71dad-62e2-4ed1-8715-da4e090aad58

Reimbursement SL 86205128-df73-4b7c-ac02-e27ce65ba292 for PackagedProductDefinition b74525af-fd3c-4ce6-aaec-5a2b7e5e581a

Metformini hydrochloridum


Marketing Authorisation 57950 for MedicinalProductDefinition 571b793d-efcd-4d56-b5b4-c0991913cbe3

Metformin-Mepha Filmtabl 500 mg 60 Stk

Metformin-Mepha Filmtabl 500 mg Ds 100 Stk

Marketing Authorisation 57950015-7169e667-fb4e-4ccd-a6d2-63e88638dfd4 for PackagedProductDefinition 7169e667-fb4e-4ccd-a6d2-63e88638dfd4

Marketing Authorisation 57950018-b3cb4533-8723-4699-9e5c-6c0ab75bb746 for PackagedProductDefinition b3cb4533-8723-4699-9e5c-6c0ab75bb746

Reimbursement SL c1bea66f-cf42-4541-a29c-4cf209126efb for PackagedProductDefinition 7169e667-fb4e-4ccd-a6d2-63e88638dfd4

Reimbursement SL 6143aa0e-f02e-4a26-958d-511e50508613 for PackagedProductDefinition b3cb4533-8723-4699-9e5c-6c0ab75bb746

Metformini hydrochloridum


Marketing Authorisation 57950 for MedicinalProductDefinition 9385199f-7149-4edb-a7f3-e5a51d640949

Metformin-Mepha Filmtbl 850 mg 30 Stk

Metformin-Mepha Filmtbl 850 mg 90 Stk

Metformin-Mepha Filmtbl 850 mg Ds 100 Stk

Marketing Authorisation 57950009-ace2471b-0ab5-4334-b553-874a68846986 for PackagedProductDefinition ace2471b-0ab5-4334-b553-874a68846986

Marketing Authorisation 57950016-7951aa67-763b-40b5-ad74-5295e26491ea for PackagedProductDefinition 7951aa67-763b-40b5-ad74-5295e26491ea

Marketing Authorisation 57950019-717e0197-55be-4a78-96ac-12b417045b53 for PackagedProductDefinition 717e0197-55be-4a78-96ac-12b417045b53

Reimbursement SL 6f862a92-86f6-4473-bd40-84fa73227af9 for PackagedProductDefinition ace2471b-0ab5-4334-b553-874a68846986

Reimbursement SL 826a62bd-9e46-47e2-9222-105652187ac7 for PackagedProductDefinition 7951aa67-763b-40b5-ad74-5295e26491ea

Reimbursement SL 43357321-d485-4cb1-872b-24e18a43b6fe for PackagedProductDefinition 717e0197-55be-4a78-96ac-12b417045b53

Metformini hydrochloridum


Marketing Authorisation 57950 for MedicinalProductDefinition 7fb1da27-9159-4138-98e8-9ce340f06504

Metformin-Mepha Filmtbl 1000 mg 60 Stk

Metformin-Mepha Filmtbl 1000 mg Ds 100 Stk

Metformin-Mepha Filmtbl 1000 mg 120 Stk

Marketing Authorisation 57950011-b6d85333-090d-46e6-9ec5-553b57d78317 for PackagedProductDefinition b6d85333-090d-46e6-9ec5-553b57d78317

Marketing Authorisation 57950020-c127e645-5f3d-4e10-9559-c5b273baffd6 for PackagedProductDefinition c127e645-5f3d-4e10-9559-c5b273baffd6

Marketing Authorisation 57950014-eb6e8907-7cbc-458d-a925-14c80256a630 for PackagedProductDefinition eb6e8907-7cbc-458d-a925-14c80256a630

Reimbursement SL 0d1357d4-6072-43cc-9095-04d20d559df2 for PackagedProductDefinition b6d85333-090d-46e6-9ec5-553b57d78317

Reimbursement SL fb314b01-2d86-4f2a-93f4-68a31775e4f4 for PackagedProductDefinition c127e645-5f3d-4e10-9559-c5b273baffd6

Reimbursement SL 48a65a9e-9d50-4b57-8f39-c6e7e97cabfd for PackagedProductDefinition eb6e8907-7cbc-458d-a925-14c80256a630

Metformini hydrochloridum


Marketing Authorisation 68510 for MedicinalProductDefinition 2f85e4f5-8206-4673-9007-45fdf387726a

Metformin Spirig HC Filmtabl 500 mg Blist 50 Stk

Marketing Authorisation 68510001-91e100f4-dd18-4523-ae16-7def586c26d4 for PackagedProductDefinition 91e100f4-dd18-4523-ae16-7def586c26d4

Reimbursement SL d45784bf-a883-4ef5-bed0-b2fd0666a0bf for PackagedProductDefinition 91e100f4-dd18-4523-ae16-7def586c26d4

Metformini hydrochloridum


Marketing Authorisation 68510 for MedicinalProductDefinition 64a6e329-9425-4f1f-a226-112cae10d319

Metformin Spirig HC Filmtabl 850 mg Blist 30 Stk

Metformin Spirig HC Filmtabl 850 mg Blist 100 Stk

Marketing Authorisation 68510003-18ab870d-3e62-4ee5-9fca-470043c71908 for PackagedProductDefinition 18ab870d-3e62-4ee5-9fca-470043c71908

Reimbursement SL 2f1234b7-c616-4d21-bfae-41923276fb9c for PackagedProductDefinition 664947cf-34f6-4459-90b0-97705d275481

Reimbursement SL 93ffe24b-ecc1-4220-bb97-f1b1d8b47a4c for PackagedProductDefinition 18ab870d-3e62-4ee5-9fca-470043c71908

Metformini hydrochloridum


Marketing Authorisation 68510 for MedicinalProductDefinition 1e0f0a66-a06a-4741-8fd0-40087e4593cf

Metformin Spirig HC Filmtabl 1000 mg Blist 60 Stk

Metformin Spirig HC Filmtabl 1000 mg Blist 120 Stk

Marketing Authorisation 68510004-be72fbd7-f926-410d-9bed-1ee73101b4b6 for PackagedProductDefinition be72fbd7-f926-410d-9bed-1ee73101b4b6

Marketing Authorisation 68510005-18090a16-de15-43cd-bb3a-51c161313f4f for PackagedProductDefinition 18090a16-de15-43cd-bb3a-51c161313f4f

Reimbursement SL a67a9b0d-f3e7-4b1b-b0ee-400df85b8902 for PackagedProductDefinition be72fbd7-f926-410d-9bed-1ee73101b4b6

Reimbursement SL ecbe2a46-9d18-48da-bc01-717e64dffd56 for PackagedProductDefinition 18090a16-de15-43cd-bb3a-51c161313f4f

Metformini hydrochloridum


Marketing Authorisation 68223 for MedicinalProductDefinition cea9a71c-cfd7-490c-acc2-213f6cfae18b

Metformin Zentiva Filmtabl 500 mg 60 Stk

Marketing Authorisation 68223013-e5a29cf1-c9bf-4cb7-91ea-ca10abceb544 for PackagedProductDefinition e5a29cf1-c9bf-4cb7-91ea-ca10abceb544

Reimbursement SL 5288436d-aab8-4b71-a308-05f7726f3ab8 for PackagedProductDefinition e5a29cf1-c9bf-4cb7-91ea-ca10abceb544

Metformini hydrochloridum


Marketing Authorisation 68223 for MedicinalProductDefinition 56f687e3-4aa2-4f69-8396-6b9c1a85d43f

Metformin Zentiva Filmtabl 850 mg 40 Stk

Metformin Zentiva Filmtabl 850 mg 100 Stk

Marketing Authorisation 68223014-636ffba5-93e8-40a9-b915-8faf12fcd9ae for PackagedProductDefinition 636ffba5-93e8-40a9-b915-8faf12fcd9ae

Marketing Authorisation 68223015-239605f3-f41d-4aa6-854c-42e4d254b1af for PackagedProductDefinition 239605f3-f41d-4aa6-854c-42e4d254b1af

Reimbursement SL 576c7176-d970-4b3e-bb63-e990c4979597 for PackagedProductDefinition 636ffba5-93e8-40a9-b915-8faf12fcd9ae

Reimbursement SL 479d5813-674c-430f-ad0f-a5a0f83da3e6 for PackagedProductDefinition 239605f3-f41d-4aa6-854c-42e4d254b1af

Metformini hydrochloridum


Marketing Authorisation 68223 for MedicinalProductDefinition 9c5f1155-c9b9-44a3-a249-830563c2d510

Metformin Zentiva Filmtabl 1000 mg 60 Stk

Metformin Zentiva Filmtabl 1000 mg 120 Stk

Marketing Authorisation 68223016-49bbca7f-ff2b-4593-b33b-74b9fe1b9dee for PackagedProductDefinition 49bbca7f-ff2b-4593-b33b-74b9fe1b9dee

Marketing Authorisation 68223017-4b5ad1f9-cd3b-49ed-b1a6-2e0d183595bd for PackagedProductDefinition 4b5ad1f9-cd3b-49ed-b1a6-2e0d183595bd

Reimbursement SL 574b7b25-cc8e-438d-a349-bbe12a71fdc8 for PackagedProductDefinition 49bbca7f-ff2b-4593-b33b-74b9fe1b9dee

Reimbursement SL 60c73a9e-6f1e-4fba-a277-fa5363719a86 for PackagedProductDefinition 4b5ad1f9-cd3b-49ed-b1a6-2e0d183595bd

Metformini hydrochloridum


Marketing Authorisation 69406 for MedicinalProductDefinition 2ea0830d-9517-4ba4-9725-4ba9413f3ad1

Methaddict Tabl 80 mg Blist 20 Stk

Medicinal product subject to medical or veterinary prescription single dispensation (A)

Methaddict Tabl 80 mg Blist 50 Stk

Methaddict Tabl 80 mg Blist 70 Stk

Marketing Authorisation 69406001-3db27045-7773-4896-bfeb-2669eb712ef2 for PackagedProductDefinition 3db27045-7773-4896-bfeb-2669eb712ef2

Marketing Authorisation 69406002-a00947a5-0467-4c6b-8864-9b2b0c2a7489 for PackagedProductDefinition a00947a5-0467-4c6b-8864-9b2b0c2a7489

Marketing Authorisation 69406003-d242bb73-cdc7-47b9-8e05-fd3552778931 for PackagedProductDefinition d242bb73-cdc7-47b9-8e05-fd3552778931

Reimbursement SL 565ff6ef-f517-4d70-8826-7614c8572d2b for PackagedProductDefinition 3db27045-7773-4896-bfeb-2669eb712ef2

Reimbursement SL ad0d6a7d-25bd-4e8a-b62c-c0d1e9df6b60 for PackagedProductDefinition a00947a5-0467-4c6b-8864-9b2b0c2a7489

Reimbursement SL 56f2ee47-7a3d-43f1-9c98-8c6e02109e04 for PackagedProductDefinition d242bb73-cdc7-47b9-8e05-fd3552778931

Methadoni hydrochloridum

Zur Anwendung im Rahmen einer Substitutionstherapie bei Opiat-/Opioidabhängigkeit bei Erwachsenen, im Rahmen einer medizinischen, sozialen und psychologischen Behandlung.


Marketing Authorisation 34385 for MedicinalProductDefinition 9ea0408d-1d16-4ab7-beaa-20ddb378ccd1

Methadon Streuli Tabl 5 mg 20 Stk

Marketing Authorisation 34385017-dbbd320b-4c97-4997-a4a1-11e5ed647c0b for PackagedProductDefinition dbbd320b-4c97-4997-a4a1-11e5ed647c0b

Reimbursement SL 4b5cd6e7-5acd-4570-97c2-6b3516939b91 for PackagedProductDefinition dbbd320b-4c97-4997-a4a1-11e5ed647c0b

Methadoni hydrochloridum


Marketing Authorisation 56552 for MedicinalProductDefinition 6a2dac30-2022-4b69-9e29-7ca149dd69eb

Methadon Streuli Tropfen 10 mg/ml Fl 100 ml

Marketing Authorisation 56552002-56bd2319-67f1-4e03-bb04-a866a3a32c5c for PackagedProductDefinition 56bd2319-67f1-4e03-bb04-a866a3a32c5c

Reimbursement SL 2fd54df9-d311-47b1-bb17-0373dfec1210 for PackagedProductDefinition 56bd2319-67f1-4e03-bb04-a866a3a32c5c

Methadoni hydrochloridum


07.10. Arthritis und rheumatische Krankheiten

07.10.60. Andere Mittel gegen Arthritis und rheumatische Krankheiten

Methotrexat Accord sol inj 7.5 mg/0.15 ml

Marketing Authorisation 66780 for MedicinalProductDefinition 652ddc25-48fa-4cf8-9dab-ed3f4a6bdc0e

Methotrexat Accord Inj Lös 7.5 mg/0.15 ml Fertspr 0.15 ml

Marketing Authorisation 66780001-5a41125f-39d2-4d3b-b2bc-cf73a0e82ea0 for PackagedProductDefinition 5a41125f-39d2-4d3b-b2bc-cf73a0e82ea0

Reimbursement SL 481867d5-7740-4d13-ad5f-209047544929 for PackagedProductDefinition 5a41125f-39d2-4d3b-b2bc-cf73a0e82ea0

Methotrexatum


Marketing Authorisation 66780 for MedicinalProductDefinition 58f208c1-e4a7-4825-8707-b8752b7e8365

Methotrexat Accord Inj Lös 10 mg/0.2 ml Fertspr 0.2 ml

Marketing Authorisation 66780005-e5c26e85-2584-4665-981d-d78bf2e65105 for PackagedProductDefinition e5c26e85-2584-4665-981d-d78bf2e65105

Reimbursement SL 8e0d3e94-798e-4c32-8da6-0e7cc50a4e62 for PackagedProductDefinition e5c26e85-2584-4665-981d-d78bf2e65105

Methotrexatum


Methotrexat Accord sol inj 12.5 mg/0.25 ml

Marketing Authorisation 66780 for MedicinalProductDefinition 4fb7f706-3c0f-4dd4-858b-ad379d1d2ce2

Methotrexat Accord Inj Lös 12.5 mg/0.25 ml Fertspr 0.25 ml

Marketing Authorisation 66780009-9a0d5c7f-7846-4b11-8720-d1d498c5e535 for PackagedProductDefinition 9a0d5c7f-7846-4b11-8720-d1d498c5e535

Reimbursement SL 437c4e12-1c8b-452b-9ea1-7c81138c0324 for PackagedProductDefinition 9a0d5c7f-7846-4b11-8720-d1d498c5e535

Methotrexatum


Marketing Authorisation 66780 for MedicinalProductDefinition 146e5e20-767e-44da-a7ac-b497dfc5bde4

Methotrexat Accord Inj Lös 15 mg/0.3 ml Fertspr 0.3 ml

Marketing Authorisation 66780013-63c53698-e7b2-41f1-818c-76f6431df805 for PackagedProductDefinition 63c53698-e7b2-41f1-818c-76f6431df805

Reimbursement SL 8850e7af-caee-411d-81c2-493e5da57831 for PackagedProductDefinition 63c53698-e7b2-41f1-818c-76f6431df805

Methotrexatum


Methotrexat Accord sol inj 17.5 mg/0.35 ml

Marketing Authorisation 66780 for MedicinalProductDefinition c2dcb2d6-dec1-487d-aa64-27fddd2ced48

Methotrexat Accord Inj Lös 17.5 mg/0.35 ml Fertspr 0.35 ml

Marketing Authorisation 66780017-41571701-63db-436b-abde-452cb989a707 for PackagedProductDefinition 41571701-63db-436b-abde-452cb989a707

Reimbursement SL 792d49ff-e01f-4237-9bab-bff17a6296c6 for PackagedProductDefinition 41571701-63db-436b-abde-452cb989a707

Methotrexatum


Marketing Authorisation 66780 for MedicinalProductDefinition 35ebe80f-1fc9-48af-ade8-f74b0e5f3dbb

Methotrexat Accord Inj Lös 20 mg/0.4 ml Fertspr 0.4 ml

Marketing Authorisation 66780021-45c4d9ff-b832-44a7-b5e8-980c5daf105c for PackagedProductDefinition 45c4d9ff-b832-44a7-b5e8-980c5daf105c

Reimbursement SL 76661be9-8ace-4fb7-9134-3f29a4756fd8 for PackagedProductDefinition 45c4d9ff-b832-44a7-b5e8-980c5daf105c

Methotrexatum


Methotrexat Accord sol inj 22.5 mg/0.45 ml

Marketing Authorisation 66780 for MedicinalProductDefinition a04bc486-3c2f-4144-94a5-1dab664b0b4c

Methotrexat Accord Inj Lös 22.5 mg/0.45 ml Fertspr 0.45 ml

Marketing Authorisation 66780025-ea85cc45-1214-42c6-87f2-19365f41fb16 for PackagedProductDefinition ea85cc45-1214-42c6-87f2-19365f41fb16

Reimbursement SL 991e0095-0c71-4aef-a321-4fabb8fe9831 for PackagedProductDefinition ea85cc45-1214-42c6-87f2-19365f41fb16

Methotrexatum


Marketing Authorisation 66780 for MedicinalProductDefinition da9136a6-a9b5-46a0-b61d-dd4692bcf846

Methotrexat Accord Inj Lös 25 mg/0.5 ml Fertspr 0.5 ml

Marketing Authorisation 66780029-0cfb337c-5a0f-4586-9666-ebf9b90e88b4 for PackagedProductDefinition 0cfb337c-5a0f-4586-9666-ebf9b90e88b4

Reimbursement SL 59bce059-c55e-40e6-b5a1-2e47935a473e for PackagedProductDefinition 0cfb337c-5a0f-4586-9666-ebf9b90e88b4

Methotrexatum


Methotrexat Accord sol inj 27.5 mg/0.55 ml

Marketing Authorisation 66780 for MedicinalProductDefinition d196852f-7d09-42d8-a66f-8e07c873d221

Methotrexat Accord Inj Lös 27.5 mg/0.55 ml Fertspr 0.55 ml

Marketing Authorisation 66780033-3c4af72d-a344-45a5-ab72-38285aae2236 for PackagedProductDefinition 3c4af72d-a344-45a5-ab72-38285aae2236

Reimbursement SL e35529b1-1927-425d-a9ac-94df89d6df1d for PackagedProductDefinition 3c4af72d-a344-45a5-ab72-38285aae2236

Methotrexatum


Marketing Authorisation 66780 for MedicinalProductDefinition f6cc8b44-ce2b-4cc6-be87-7cf3f629a573

Methotrexat Accord Inj Lös 30 mg/0.6 ml Fertspr 0.6 ml

Reimbursement SL ce18d507-be78-41c3-ba38-0b0485e2357b for PackagedProductDefinition d971e803-789e-4554-8916-0a00392c92ec

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition d0f67e50-c0ea-42da-b20c-58e52b4dfae6

Methotrexat Accord Inj Lös 7.5 mg/0.15 ml Fertinj 0.15 ml

Marketing Authorisation 68244001-e077182d-af9d-4144-9c63-571507edd68d for PackagedProductDefinition e077182d-af9d-4144-9c63-571507edd68d

Reimbursement SL dfbf5b37-916d-42d2-bc01-e9c12ebe6d63 for PackagedProductDefinition e077182d-af9d-4144-9c63-571507edd68d

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition a6c8692c-16cc-43b1-a67b-8a13a19f5537

Methotrexat Accord Inj Lös 10 mg/0.2 ml Fertinj 0.2 ml

Marketing Authorisation 68244002-783ddc90-73a9-448e-85ae-290260c66b54 for PackagedProductDefinition 783ddc90-73a9-448e-85ae-290260c66b54

Reimbursement SL 5383a89e-eb1c-4295-b548-cefb551788ee for PackagedProductDefinition 783ddc90-73a9-448e-85ae-290260c66b54

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition 7a1be6b3-e1ad-43bc-b19b-1c9aa9fe777a

Methotrexat Accord Inj Lös 12.5 mg/0.25 ml Fertinj 0.25 ml

Marketing Authorisation 68244003-da91eefa-ab42-4944-9a48-d89af7d307f3 for PackagedProductDefinition da91eefa-ab42-4944-9a48-d89af7d307f3

Reimbursement SL ae6c73e9-d5a1-49b1-8360-7a058ed4f437 for PackagedProductDefinition da91eefa-ab42-4944-9a48-d89af7d307f3

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition 79fc171c-6cf5-42ba-990e-9bd7bee92abe

Methotrexat Accord Inj Lös 15 mg/0.3 ml Fertinj 0.3 ml

Marketing Authorisation 68244004-cc7ae223-fb5e-445b-8a93-50be45e54e3e for PackagedProductDefinition cc7ae223-fb5e-445b-8a93-50be45e54e3e

Reimbursement SL be146e15-e70d-4cf9-bb85-1a39577cc41b for PackagedProductDefinition cc7ae223-fb5e-445b-8a93-50be45e54e3e

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition 36983ac0-3518-4a7c-b822-530d48115f8c

Methotrexat Accord Inj Lös 17.5 mg/0.35 ml Fertinj 0.35 ml

Marketing Authorisation 68244005-0c1e90bd-c7f0-4594-90c5-a12a27a48e4d for PackagedProductDefinition 0c1e90bd-c7f0-4594-90c5-a12a27a48e4d

Reimbursement SL 17408951-4638-48ae-a6d1-5fe879f8afa9 for PackagedProductDefinition 0c1e90bd-c7f0-4594-90c5-a12a27a48e4d

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition 95ab8040-d46e-479a-ba65-be257e0d72ab

Methotrexat Accord Inj Lös 20 mg/0.4 ml Fertinj 0.4 ml

Marketing Authorisation 68244006-4d52daa3-09c1-4618-8d57-e4cb4fca11ea for PackagedProductDefinition 4d52daa3-09c1-4618-8d57-e4cb4fca11ea

Reimbursement SL b70b4dff-237d-4faf-83b9-5442d985f5e4 for PackagedProductDefinition 4d52daa3-09c1-4618-8d57-e4cb4fca11ea

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition e503fe58-8c61-4c73-8f7f-be53e6712da5

Methotrexat Accord Inj Lös 22.5 mg/0.45 ml Fertinj 0.45 ml

Marketing Authorisation 68244007-aed38fc1-96fd-47bf-9c63-b72be45fd3df for PackagedProductDefinition aed38fc1-96fd-47bf-9c63-b72be45fd3df

Reimbursement SL dad4e448-03d4-4ea2-97ac-c2246a6d2edb for PackagedProductDefinition aed38fc1-96fd-47bf-9c63-b72be45fd3df

Methotrexatum


Marketing Authorisation 68244 for MedicinalProductDefinition 351ad5de-878f-4a9a-ab20-5f43c17213c7

Methotrexat Accord Inj Lös 25 mg/0.5 ml Fertinj 0.5 ml

Marketing Authorisation 68244008-0c8ac4e3-0d31-4e2c-8d8b-848f3f70c008 for PackagedProductDefinition 0c8ac4e3-0d31-4e2c-8d8b-848f3f70c008

Reimbursement SL 655cc7a8-b6e3-4972-a8fa-cae169194249 for PackagedProductDefinition 0c8ac4e3-0d31-4e2c-8d8b-848f3f70c008

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 7.5 mg/0.3 ml

Marketing Authorisation 65510 for MedicinalProductDefinition f5e8892f-ceca-45d4-820d-1dee721da3ac

Methotrexat-Mepha rheuma/derm Inj Lös 7.5 mg/0.3 ml Fertspr 1 Stk

Marketing Authorisation 65510002-65ee1236-aed0-421d-bdab-bab2ba3293ad for PackagedProductDefinition 65ee1236-aed0-421d-bdab-bab2ba3293ad

Reimbursement SL 36bb5d99-9bf2-4089-bc26-bb4ff3c6b9f8 for PackagedProductDefinition 65ee1236-aed0-421d-bdab-bab2ba3293ad

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 10 mg/0.4 ml

Marketing Authorisation 65510 for MedicinalProductDefinition 848e1515-07c7-42c8-82f8-5860e887a02e

Methotrexat-Mepha rheuma/derm Inj Lös 10 mg/0.4 ml Fertspr 1 Stk

Marketing Authorisation 65510003-22a727a5-77b6-4fea-90fe-612356e7a581 for PackagedProductDefinition 22a727a5-77b6-4fea-90fe-612356e7a581

Reimbursement SL 0fb8f6bc-5a26-4b75-bfd8-d07c41662cbd for PackagedProductDefinition 22a727a5-77b6-4fea-90fe-612356e7a581

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 12.5 mg/0.3125 ml

Marketing Authorisation 65510 for MedicinalProductDefinition 58e0eabb-ae0c-46db-a199-49b06c81ab64

Methotrexat-Mepha rheuma/derm Inj Lös 12.5 mg/0.3125 ml Fertspr 1 Stk

Marketing Authorisation 65510004-9dc84edc-070d-42f9-ab58-b240b6ff8250 for PackagedProductDefinition 9dc84edc-070d-42f9-ab58-b240b6ff8250

Reimbursement SL e779a3f6-d83b-49a3-9de7-e6cec5902761 for PackagedProductDefinition 9dc84edc-070d-42f9-ab58-b240b6ff8250

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 15 mg/0.375 ml

Marketing Authorisation 65510 for MedicinalProductDefinition 3733b8dc-11ac-4414-b158-6216d8566c70

Methotrexat-Mepha rheuma/derm Inj Lös 15 mg/0.375 ml Fertspr 1 Stk

Marketing Authorisation 65510005-475bc94b-627d-486d-8e9e-e4963ece0c92 for PackagedProductDefinition 475bc94b-627d-486d-8e9e-e4963ece0c92

Reimbursement SL 02166b47-b6dc-46fd-9af3-f4b21bf9dd12 for PackagedProductDefinition 475bc94b-627d-486d-8e9e-e4963ece0c92

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 17.5 mg/0.4375 ml

Marketing Authorisation 65510 for MedicinalProductDefinition 48d3de3a-77e2-4d7e-bb66-1c0f96d43a56

Methotrexat-Mepha rheuma/derm Inj Lös 17.5 mg/0.4375 ml Fertspr 1 Stk

Marketing Authorisation 65510006-2e8833b3-c0d7-4f24-9c1b-426e77d0f609 for PackagedProductDefinition 2e8833b3-c0d7-4f24-9c1b-426e77d0f609

Reimbursement SL f408d5f2-0029-4fbc-9a8e-38823e7d6321 for PackagedProductDefinition 2e8833b3-c0d7-4f24-9c1b-426e77d0f609

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 20 mg/0.5 ml

Marketing Authorisation 65510 for MedicinalProductDefinition 0e8d28e7-9330-452a-9717-aaf16e18fd1b

Methotrexat-Mepha rheuma/derm Inj Lös 20 mg/0.5 ml Fertspr 1 Stk

Marketing Authorisation 65510007-f7b51ef4-ff0e-4092-840d-c1d3ca6ed0e0 for PackagedProductDefinition f7b51ef4-ff0e-4092-840d-c1d3ca6ed0e0

Reimbursement SL 118a87c1-bec5-487d-8144-bb6368a278d2 for PackagedProductDefinition f7b51ef4-ff0e-4092-840d-c1d3ca6ed0e0

Methotrexatum


Methotrexat-Mepha rheuma/derm sol inj 25 mg/0.625 ml

Marketing Authorisation 65510 for MedicinalProductDefinition 5795091b-3329-409a-8324-83888024de8d

Methotrexat-Mepha rheuma/derm Inj Lös 25 mg/0.625 ml Fertspr 1 Stk

Marketing Authorisation 65510008-58f7c89e-2a92-4f50-b4e3-e31f7faddd8e for PackagedProductDefinition 58f7c89e-2a92-4f50-b4e3-e31f7faddd8e

Reimbursement SL 369d76d0-9b12-4ead-b68e-acd0282e0fd4 for PackagedProductDefinition 58f7c89e-2a92-4f50-b4e3-e31f7faddd8e

Methotrexatum


Methotrexat Orion rheuma/derm cpr 2.5 mg

Marketing Authorisation 66019 for MedicinalProductDefinition ba305dd5-f5b3-4646-98a3-9a38da30ac3a

Methotrexat Orion rheuma/derm Tabl 2.5 mg Ds 20 Stk

Methotrexat Orion rheuma/derm Tabl 2.5 mg Blist 20 Stk

Marketing Authorisation 66019003-5d09d0b1-b0a2-48e6-be86-85b6f9bd2524 for PackagedProductDefinition 5d09d0b1-b0a2-48e6-be86-85b6f9bd2524

Marketing Authorisation 66019005-cf9daac0-a1c9-4631-a089-03d5f539325c for PackagedProductDefinition cf9daac0-a1c9-4631-a089-03d5f539325c

Reimbursement SL 41006101-3a3c-46bd-ad78-2fe8802ae453 for PackagedProductDefinition 5d09d0b1-b0a2-48e6-be86-85b6f9bd2524

Reimbursement SL 605161bc-7c70-4d49-9f2a-4fe4504ab38f for PackagedProductDefinition cf9daac0-a1c9-4631-a089-03d5f539325c

Methotrexatum


Marketing Authorisation 66019 for MedicinalProductDefinition d3ea7dc9-f02b-4e56-8521-f60df6097050

Methotrexat Orion rheuma/derm Tabl 10 mg Ds 10 Stk

Methotrexat Orion rheuma/derm Tabl 10 mg Blist 10 Stk

Marketing Authorisation 66019004-9432d5e6-9b7f-474f-8450-65062d37c1f3 for PackagedProductDefinition 9432d5e6-9b7f-474f-8450-65062d37c1f3

Marketing Authorisation 66019006-f4f0241e-c4cb-4d90-9874-c185a49393c0 for PackagedProductDefinition f4f0241e-c4cb-4d90-9874-c185a49393c0

Reimbursement SL a181d8e6-968e-4bff-815b-06f7c260c040 for PackagedProductDefinition 9432d5e6-9b7f-474f-8450-65062d37c1f3

Reimbursement SL 8f753cae-975d-45ab-9557-f739bd72764a for PackagedProductDefinition f4f0241e-c4cb-4d90-9874-c185a49393c0

Methotrexatum


Marketing Authorisation 58370 for MedicinalProductDefinition f143fe88-5162-4e1d-be90-948ecf152b0c

Methotrexat Sandoz Tabl 10 mg Blist 10 Stk

Marketing Authorisation 58370006-23a9fc62-a265-4aa9-8c71-b595d823d3cc for PackagedProductDefinition 23a9fc62-a265-4aa9-8c71-b595d823d3cc

Reimbursement SL f78ace9a-8ebf-4715-b04f-cc09d6195c42 for PackagedProductDefinition 23a9fc62-a265-4aa9-8c71-b595d823d3cc

Methotrexatum


Marketing Authorisation 58370 for MedicinalProductDefinition 2cb63c16-1ec5-4538-931a-8ae377516306

Methotrexat Sandoz Tabl 5 mg Blist 20 Stk

Marketing Authorisation 58370005-e41a316b-2d72-47e7-a13e-b364c7792a88 for PackagedProductDefinition e41a316b-2d72-47e7-a13e-b364c7792a88

Reimbursement SL 8d3645a2-f27b-4732-b64f-c0125d9f88e8 for PackagedProductDefinition e41a316b-2d72-47e7-a13e-b364c7792a88

Methotrexatum


Marketing Authorisation 51079 for MedicinalProductDefinition b141ae1b-2d6a-4348-a1e5-565d48ed11ce

Methotrexat Sandoz Inf Konz 5000 mg Durchstf 50 ml

Marketing Authorisation 51079029-3f67b029-e760-4a15-a66c-f18c11fbbaa8 for PackagedProductDefinition 3f67b029-e760-4a15-a66c-f18c11fbbaa8

Reimbursement SL e79f5ba5-9cd0-4899-9f47-ae39239047aa for PackagedProductDefinition 3f67b029-e760-4a15-a66c-f18c11fbbaa8

Methotrexatum


Marketing Authorisation 47999 for MedicinalProductDefinition ec930512-5d66-4320-99fd-82ff2ab4815c

Methotrexat-Teva onco Inj Lös 50 mg/2ml Durchstf 2 ml

Marketing Authorisation 47999001-756af8e8-25a3-4245-846b-5887c8a66b31 for PackagedProductDefinition 756af8e8-25a3-4245-846b-5887c8a66b31

Reimbursement SL 39530ebb-ddf2-41d2-8bed-9b2d21b084e0 for PackagedProductDefinition 756af8e8-25a3-4245-846b-5887c8a66b31

Methotrexatum


Methotrexat-Teva onco sol inj 500 mg/20ml

Marketing Authorisation 47999 for MedicinalProductDefinition f3b4486f-9787-4cad-9109-4f479d68ed30

Methotrexat-Teva onco Inj Lös 500 mg/20ml 20 ml

Marketing Authorisation 47999002-3673e697-27c5-42cc-a43e-8c0ca6e53a0a for PackagedProductDefinition 3673e697-27c5-42cc-a43e-8c0ca6e53a0a

Reimbursement SL 6554580a-abaf-46d8-aaf5-8c416949fd1e for PackagedProductDefinition 3673e697-27c5-42cc-a43e-8c0ca6e53a0a

Methotrexatum


Methotrexat-Teva onco sol inj 5000 mg/50ml

Marketing Authorisation 47999 for MedicinalProductDefinition 7c864cda-ef60-4c74-938a-3e3f53fca6b3

Methotrexat-Teva onco Inj Lös 5000 mg/50ml 50 ml

Marketing Authorisation 47999004-ce102123-dcc1-4855-8803-c43ec024175f for PackagedProductDefinition ce102123-dcc1-4855-8803-c43ec024175f

Reimbursement SL 055cdeeb-8579-4786-8401-4cc242636251 for PackagedProductDefinition ce102123-dcc1-4855-8803-c43ec024175f

Methotrexatum


Marketing Authorisation 62083 for MedicinalProductDefinition e4394199-b9f5-4a13-aa5d-fa6f8dcf4c03

Methrexx Inj Lös 7.5 mg/0.375ml Fertspr 0.375 ml

Marketing Authorisation 62083008-65ee74be-b0e5-4ffe-8126-81b765708a0c for PackagedProductDefinition 65ee74be-b0e5-4ffe-8126-81b765708a0c

Reimbursement SL 708b0b13-973b-4eff-a289-2f91046e57c6 for PackagedProductDefinition 65ee74be-b0e5-4ffe-8126-81b765708a0c

Methotrexatum

Wird nicht vergütet in folgender Indikation: Leichter bis mittelschwerer Morbus Crohn, entweder allein oder in Kombination mit Kortikosteroiden bei erwachsenen Patienten, die auf Thiopurine nicht ansprechen oder diese nicht vertragen.


Marketing Authorisation 62083 for MedicinalProductDefinition b5f0a2dd-f89f-40cc-b6aa-1a1f746b184b

Methrexx Inj Lös 10 mg/0.5ml Fertspr 0.5 ml

Marketing Authorisation 62083009-badb5905-5273-43a7-9918-cbdf85616090 for PackagedProductDefinition badb5905-5273-43a7-9918-cbdf85616090

Reimbursement SL f8b06f09-e2b0-428f-b0fd-253f4a2df146 for PackagedProductDefinition badb5905-5273-43a7-9918-cbdf85616090

Methotrexatum


Marketing Authorisation 62083 for MedicinalProductDefinition 6dc23090-2dff-4883-a638-4fbfbc167c93

Methrexx Inj Lös 12.5 mg/0.625ml Fertspr 0.625 ml

Marketing Authorisation 62083010-2fb38e07-b222-478d-a27b-1abee9b2f667 for PackagedProductDefinition 2fb38e07-b222-478d-a27b-1abee9b2f667

Reimbursement SL 3e48861f-0482-49f0-94f2-5d946658c18e for PackagedProductDefinition 2fb38e07-b222-478d-a27b-1abee9b2f667

Methotrexatum


Marketing Authorisation 62083 for MedicinalProductDefinition 3dee49f9-9291-4296-b99f-047dd5fbbf59

Methrexx Inj Lös 15 mg/0.75ml Fertspr 0.75 ml

Marketing Authorisation 62083014-5ce0613a-9525-48c4-ae34-7bf99a8efdaa for PackagedProductDefinition 5ce0613a-9525-48c4-ae34-7bf99a8efdaa

Reimbursement SL c6e23813-9237-4a37-999c-66f7c568de87 for PackagedProductDefinition 5ce0613a-9525-48c4-ae34-7bf99a8efdaa

Methotrexatum


Marketing Authorisation 62083 for MedicinalProductDefinition 86bc143d-47a4-4efa-a76d-61d95bcc39bd

Methrexx Inj Lös 17.5 mg/0.875ml Fertspr 0.875 ml

Marketing Authorisation 62083011-619a7629-a517-4fb3-b534-8dc958c4ec63 for PackagedProductDefinition 619a7629-a517-4fb3-b534-8dc958c4ec63

Reimbursement SL 50da1f5c-a031-419e-96fb-8da0800a369d for PackagedProductDefinition 619a7629-a517-4fb3-b534-8dc958c4ec63

Methotrexatum

Wird nicht vergütet in folgender Indikation: Leichter bis mittelschwerer Morbus Crohn, entweder allein oder in Kombination mit Kortikosteroiden bei erwachsenen Patienten, die auf Thiopurine nicht ansprechen oder diese nicht vertragen.


Marketing Authorisation 62083 for MedicinalProductDefinition d8f1dc4c-060f-4db9-8458-56f834941949

Methrexx Inj Lös 20 mg/ml Fertspr 1 Stk

Marketing Authorisation 62083005-7e3a481f-3c79-44f9-8239-6f172073feb1 for PackagedProductDefinition 7e3a481f-3c79-44f9-8239-6f172073feb1

Reimbursement SL 21423546-67e6-40aa-9c1b-cb76641f16e2 for PackagedProductDefinition 7e3a481f-3c79-44f9-8239-6f172073feb1

Methotrexatum


Marketing Authorisation 62083 for MedicinalProductDefinition 34c48786-9ea1-4ead-95b8-463d7235b6e2

Methrexx Inj Lös 25 mg/1.25ml Fertspr 1 Stk

Marketing Authorisation 62083006-5231d69b-bf41-4d0a-b69a-9b4707f998ec for PackagedProductDefinition 5231d69b-bf41-4d0a-b69a-9b4707f998ec

Reimbursement SL 95f09460-4d87-4fd7-ab06-e627c50d05fb for PackagedProductDefinition 5231d69b-bf41-4d0a-b69a-9b4707f998ec

Methotrexatum


Marketing Authorisation 62083 for MedicinalProductDefinition 4bfd7878-1079-4950-a244-93f80117fb94

Methrexx Inj Lös 30 mg/1.5ml Fertspr 1 Stk

Marketing Authorisation 62083007-695db0a4-1a1b-48e1-a624-87a2616ee5e0 for PackagedProductDefinition 695db0a4-1a1b-48e1-a624-87a2616ee5e0

Reimbursement SL c09a2514-9025-4c11-b212-b2e41bb592ff for PackagedProductDefinition 695db0a4-1a1b-48e1-a624-87a2616ee5e0

Methotrexatum


Marketing Authorisation 66445 for MedicinalProductDefinition 1ff7c35f-88ad-4668-8758-73a77b968032

Methylphenidat-Mepha Ret Tabl 18 mg Ds 30 Stk

Methylphenidat-Mepha Ret Tabl 18 mg Ds 60 Stk

Marketing Authorisation 66445001-e3ca0c50-adae-42d1-b272-62d64f705bd8 for PackagedProductDefinition e3ca0c50-adae-42d1-b272-62d64f705bd8

Marketing Authorisation 66445002-d0bf7bc1-9334-4c71-9bf7-59eadb14eb0c for PackagedProductDefinition d0bf7bc1-9334-4c71-9bf7-59eadb14eb0c

Reimbursement SL a60c0138-66d2-4337-8de8-6631cf1db347 for PackagedProductDefinition e3ca0c50-adae-42d1-b272-62d64f705bd8

Reimbursement SL 079e1b9a-1bde-4cdc-8578-c87daa3ca7cd for PackagedProductDefinition d0bf7bc1-9334-4c71-9bf7-59eadb14eb0c

Methylphenidati hydrochloridum

Kinder ab 6 Jahren, Jugendliche und Erwachsene: Diagnosestellung durch einen Facharzt der Kinder- und Jugendmedizin mit Schwerpunkt Entwicklungspädiatrie oder einen Facharzt der Psychiatrie und Psychotherapie, Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen, Behandlung im Rahmen eines umfassenden Therapieprogramms, Bei Erwachsenen müssen entsprechende Symptome bereits in der Kindheit bestanden haben.


Marketing Authorisation 66445 for MedicinalProductDefinition 122e3a4c-161c-45a3-9cbb-5cdac2ce3667

Methylphenidat-Mepha Ret Tabl 27 mg Ds 30 Stk

Methylphenidat-Mepha Ret Tabl 27 mg Ds 60 Stk

Marketing Authorisation 66445004-d5b5754e-37fe-4866-ad97-aae2b7b7708f for PackagedProductDefinition d5b5754e-37fe-4866-ad97-aae2b7b7708f

Reimbursement SL 7aef2366-a996-4433-8c71-58ff7baeec18 for PackagedProductDefinition 79d35cd3-15f8-4c29-9754-00a9760b0598

Reimbursement SL 8f9bd3e9-74ed-4dc3-b052-ac2a2bd86e45 for PackagedProductDefinition d5b5754e-37fe-4866-ad97-aae2b7b7708f

Methylphenidati hydrochloridum


Marketing Authorisation 66445 for MedicinalProductDefinition f3c21789-8a89-43d9-a5b2-9b76e72e7884

Methylphenidat-Mepha Ret Tabl 36 mg Ds 30 Stk

Methylphenidat-Mepha Ret Tabl 36 mg Ds 60 Stk

Marketing Authorisation 66445005-857a93aa-8ad2-46d3-b10c-a6ca91c0b61f for PackagedProductDefinition 857a93aa-8ad2-46d3-b10c-a6ca91c0b61f

Marketing Authorisation 66445006-395d9ed8-b2f3-4054-920e-8ceae3e71bd3 for PackagedProductDefinition 395d9ed8-b2f3-4054-920e-8ceae3e71bd3

Reimbursement SL e2b28f5f-ca08-4b8d-b19f-32a25a3d569e for PackagedProductDefinition 857a93aa-8ad2-46d3-b10c-a6ca91c0b61f

Reimbursement SL ace9f5fe-b768-4a43-ab66-af7ce64fe008 for PackagedProductDefinition 395d9ed8-b2f3-4054-920e-8ceae3e71bd3

Methylphenidati hydrochloridum


Marketing Authorisation 66445 for MedicinalProductDefinition 546fef0e-f9f1-43a1-ae8e-99fcaf6450c6

Methylphenidat-Mepha Ret Tabl 54 mg Ds 30 Stk

Methylphenidat-Mepha Ret Tabl 54 mg Ds 60 Stk

Marketing Authorisation 66445007-72d1f050-537d-40f6-b68d-748dbb85f139 for PackagedProductDefinition 72d1f050-537d-40f6-b68d-748dbb85f139

Marketing Authorisation 66445008-0d91b176-fc8a-40fa-bbcc-51b68fed3fdc for PackagedProductDefinition 0d91b176-fc8a-40fa-bbcc-51b68fed3fdc

Reimbursement SL 813594f5-a279-4edd-b95f-db3fcff8dbb0 for PackagedProductDefinition 72d1f050-537d-40f6-b68d-748dbb85f139

Reimbursement SL 4208b460-a130-40a2-a3d6-cd95614042d3 for PackagedProductDefinition 0d91b176-fc8a-40fa-bbcc-51b68fed3fdc

Methylphenidati hydrochloridum

Kinder ab 6 Jahren, Jugendliche und Erwachsene: Diagnosestellung durch einen Facharzt der Kinder- und Jugendmedizin mit Schwerpunkt Entwicklungspädiatrie oder einen Facharzt der Psychiatrie und Psychotherapie, Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen, Behandlung im Rahmen eines umfassenden Therapieprogramms, Bei Erwachsenen müssen entsprechende Symptome bereits in der Kindheit bestanden haben.


Marketing Authorisation 66993 for MedicinalProductDefinition 23cd3e2d-c4dc-4512-840d-ffd39ccd4c38

Methylphenidat-Mepha LA Depocaps 10 mg 30 Stk

Methylphenidat-Mepha LA Depocaps 10 mg 100 Stk

Marketing Authorisation 66993001-823aaeac-4105-4d58-8a7c-d63566b9f803 for PackagedProductDefinition 823aaeac-4105-4d58-8a7c-d63566b9f803

Marketing Authorisation 66993003-6ab9a384-8160-4e1a-81c5-647bfba8c714 for PackagedProductDefinition 6ab9a384-8160-4e1a-81c5-647bfba8c714

Reimbursement SL 639f53cd-391a-4775-9d35-d2a95d7ec123 for PackagedProductDefinition 823aaeac-4105-4d58-8a7c-d63566b9f803

Reimbursement SL 679ae02b-0149-4a2e-8b58-4355427503af for PackagedProductDefinition 6ab9a384-8160-4e1a-81c5-647bfba8c714

Methylphenidati hydrochloridum


Marketing Authorisation 66993 for MedicinalProductDefinition 2bfbf38d-2fb8-4d63-bb72-52289e969cc4

Methylphenidat-Mepha LA Depocaps 20 mg 30 Stk

Methylphenidat-Mepha LA Depocaps 20 mg 100 Stk

Marketing Authorisation 66993002-aef786b8-4d7a-41a4-81d5-89d53a458809 for PackagedProductDefinition aef786b8-4d7a-41a4-81d5-89d53a458809

Marketing Authorisation 66993006-09a5140d-710c-4aef-a958-8fe7fa8793b2 for PackagedProductDefinition 09a5140d-710c-4aef-a958-8fe7fa8793b2

Reimbursement SL 686de76c-5031-4043-917c-ed7fcd661901 for PackagedProductDefinition aef786b8-4d7a-41a4-81d5-89d53a458809

Reimbursement SL 27edb851-4279-4eeb-a0d5-027d8fd92135 for PackagedProductDefinition 09a5140d-710c-4aef-a958-8fe7fa8793b2

Methylphenidati hydrochloridum


Marketing Authorisation 66993 for MedicinalProductDefinition 811f5477-4ea7-461a-9149-52b7a8b70e1c

Methylphenidat-Mepha LA Depocaps 30 mg 30 Stk

Methylphenidat-Mepha LA Depocaps 30 mg 100 Stk

Marketing Authorisation 66993004-0a6493ac-d0ba-4f7c-a902-bc6c7b7ad23b for PackagedProductDefinition 0a6493ac-d0ba-4f7c-a902-bc6c7b7ad23b

Reimbursement SL f5223f92-841d-4c86-a2da-955157a070e5 for PackagedProductDefinition 0a6493ac-d0ba-4f7c-a902-bc6c7b7ad23b

Reimbursement SL c34245d3-1f37-4a15-a200-0593ed0718d9 for PackagedProductDefinition a4148269-4965-4426-bd75-4df93d795c82

Methylphenidati hydrochloridum


Marketing Authorisation 66993 for MedicinalProductDefinition 41f4882e-6cdc-4192-8aee-9500f3bd4e24

Methylphenidat-Mepha LA Depocaps 40 mg 30 Stk

Methylphenidat-Mepha LA Depocaps 40 mg 100 Stk

Marketing Authorisation 66993005-aadc4883-d0b4-4dcf-96cc-3f29d14f615e for PackagedProductDefinition aadc4883-d0b4-4dcf-96cc-3f29d14f615e

Marketing Authorisation 66993012-e6505c88-2188-410a-bb55-541ea6d112e6 for PackagedProductDefinition e6505c88-2188-410a-bb55-541ea6d112e6

Reimbursement SL 92e4ff2f-315b-471f-922e-0ca1a2890a25 for PackagedProductDefinition aadc4883-d0b4-4dcf-96cc-3f29d14f615e

Reimbursement SL 3d5e80f5-d36a-41cc-b2a0-6d3ff943fbb6 for PackagedProductDefinition e6505c88-2188-410a-bb55-541ea6d112e6

Methylphenidati hydrochloridum


Marketing Authorisation 62228 for MedicinalProductDefinition 443bc693-a9d1-42fc-a739-f3f09040b399

Methylphenidat Sandoz Ret Tabl 18 mg 30 Stk

Methylphenidat Sandoz Ret Tabl 18 mg 60 Stk

Marketing Authorisation 62228004-caffc63a-2cd9-4611-8290-1e1f5b0a3413 for PackagedProductDefinition caffc63a-2cd9-4611-8290-1e1f5b0a3413

Reimbursement SL bdf96d18-349e-4697-b279-4d844c0b7e72 for PackagedProductDefinition 1904267a-56f6-4f62-9df1-668106a56d10

Reimbursement SL dd4f93da-1734-4788-aabe-80208c348bc9 for PackagedProductDefinition caffc63a-2cd9-4611-8290-1e1f5b0a3413

Methylphenidati hydrochloridum

Kinder ab 6 Jahren, Jugendliche und Erwachsene: Diagnosestellung durch einen Facharzt der Kinder- und Jugendmedizin mit Schwerpunkt Entwicklungspädiatrie oder einen Facharzt der Psychiatrie und Psychotherapie, Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen, Behandlung im Rahmen eines umfassenden Therapieprogramms, Bei Erwachsenen müssen entsprechende Symptome bereits in der Kindheit bestanden haben.


Marketing Authorisation 62228 for MedicinalProductDefinition d277ce6b-1819-42f5-bc0e-1d430a834020

Methylphenidat Sandoz Ret Tabl 27 mg 30 Stk

Methylphenidat Sandoz Ret Tabl 27 mg 60 Stk

Marketing Authorisation 62228007-b2ea4adc-7ba5-4cd9-a17a-658c1baf7ca8 for PackagedProductDefinition b2ea4adc-7ba5-4cd9-a17a-658c1baf7ca8

Marketing Authorisation 62228008-3d79e835-12d2-47f3-a5bf-a25327f31299 for PackagedProductDefinition 3d79e835-12d2-47f3-a5bf-a25327f31299

Reimbursement SL 865abb87-6aee-4ba3-a9af-f8284d2b049b for PackagedProductDefinition b2ea4adc-7ba5-4cd9-a17a-658c1baf7ca8

Reimbursement SL 90f1acce-b6a1-464b-bd72-b790cac13137 for PackagedProductDefinition 3d79e835-12d2-47f3-a5bf-a25327f31299

Methylphenidati hydrochloridum


Marketing Authorisation 62228 for MedicinalProductDefinition af177dc1-68b7-42c0-8abe-87b53dd3ef0e

Methylphenidat Sandoz Ret Tabl 36 mg 30 Stk

Methylphenidat Sandoz Ret Tabl 36 mg 60 Stk

Marketing Authorisation 62228002-073ec7fb-3431-4260-8f63-bb4e367e35b2 for PackagedProductDefinition 073ec7fb-3431-4260-8f63-bb4e367e35b2

Marketing Authorisation 62228005-74b4dc46-9607-4de0-9d39-28587b1543a8 for PackagedProductDefinition 74b4dc46-9607-4de0-9d39-28587b1543a8

Reimbursement SL 2c5803b7-5178-4819-a0c3-fbb14d40624d for PackagedProductDefinition 073ec7fb-3431-4260-8f63-bb4e367e35b2

Reimbursement SL 4c894b22-d34d-4d05-89d3-32f2a2d71b6d for PackagedProductDefinition 74b4dc46-9607-4de0-9d39-28587b1543a8

Methylphenidati hydrochloridum


Marketing Authorisation 62228 for MedicinalProductDefinition 0b88c890-55bf-4735-b875-39825e4619df

Methylphenidat Sandoz Ret Tabl 54 mg 30 Stk

Methylphenidat Sandoz Ret Tabl 54 mg 60 Stk

Marketing Authorisation 62228003-dd518c6c-142d-4ad8-b4ef-875599a99a21 for PackagedProductDefinition dd518c6c-142d-4ad8-b4ef-875599a99a21

Marketing Authorisation 62228006-f89e254e-2a1d-4c78-8d5a-f996be6c70ee for PackagedProductDefinition f89e254e-2a1d-4c78-8d5a-f996be6c70ee

Reimbursement SL 912a3a5e-684b-48cc-bdde-70f52b29fc10 for PackagedProductDefinition dd518c6c-142d-4ad8-b4ef-875599a99a21

Reimbursement SL 91f7c774-2ec4-4d7f-96f9-741b82b340e6 for PackagedProductDefinition f89e254e-2a1d-4c78-8d5a-f996be6c70ee

Methylphenidati hydrochloridum

Kinder ab 6 Jahren, Jugendliche und Erwachsene: Diagnosestellung durch einen Facharzt der Kinder- und Jugendmedizin mit Schwerpunkt Entwicklungspädiatrie oder einen Facharzt der Psychiatrie und Psychotherapie, Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen, Behandlung im Rahmen eines umfassenden Therapieprogramms, Bei Erwachsenen müssen entsprechende Symptome bereits in der Kindheit bestanden haben.


Marketing Authorisation 69315 for MedicinalProductDefinition 28c0c5bb-b908-4ca2-9a83-c8431d1e6bd8

Methylphenidat Spirig HC Ret Tabl 18 mg Ds 30 Stk

Methylphenidat Spirig HC Ret Tabl 18 mg Ds 60 Stk

Marketing Authorisation 69315001-c2288a90-7b10-45f6-980b-2c84959ea384 for PackagedProductDefinition c2288a90-7b10-45f6-980b-2c84959ea384

Marketing Authorisation 69315002-d8a20acb-0e96-4c99-8817-12d913008ba2 for PackagedProductDefinition d8a20acb-0e96-4c99-8817-12d913008ba2

Reimbursement SL 69d4e9e5-b6c8-4e9c-b127-468fb10f0f10 for PackagedProductDefinition c2288a90-7b10-45f6-980b-2c84959ea384

Reimbursement SL c0df4262-e383-4552-9553-0d60040f33f0 for PackagedProductDefinition d8a20acb-0e96-4c99-8817-12d913008ba2

Methylphenidati hydrochloridum


Marketing Authorisation 69315 for MedicinalProductDefinition a51e7503-b51d-4642-8cee-5b5f92306ff0

Methylphenidat Spirig HC Ret Tabl 27 mg Ds 30 Stk

Methylphenidat Spirig HC Ret Tabl 27 mg Ds 60 Stk

Marketing Authorisation 69315003-507db16d-60f9-46df-a1ec-a81567f98317 for PackagedProductDefinition 507db16d-60f9-46df-a1ec-a81567f98317

Marketing Authorisation 69315004-c2c03a1d-eeb6-4c28-9e4b-983d101de083 for PackagedProductDefinition c2c03a1d-eeb6-4c28-9e4b-983d101de083

Reimbursement SL 4245f89b-9c30-4cd2-b1c0-bfe726eb5694 for PackagedProductDefinition 507db16d-60f9-46df-a1ec-a81567f98317

Reimbursement SL ebaada0d-47ab-4eae-aca3-b21206c1011d for PackagedProductDefinition c2c03a1d-eeb6-4c28-9e4b-983d101de083

Methylphenidati hydrochloridum


Marketing Authorisation 69315 for MedicinalProductDefinition da8b37e9-017e-4cd0-b39a-146f768d31d3

Methylphenidat Spirig HC Ret Tabl 36 mg Ds 30 Stk

Methylphenidat Spirig HC Ret Tabl 36 mg Ds 60 Stk

Marketing Authorisation 69315006-41b3f63e-209c-45a8-8ce1-7cb6e6ba138e for PackagedProductDefinition 41b3f63e-209c-45a8-8ce1-7cb6e6ba138e

Reimbursement SL 24aaeb52-0f8a-4dc7-8dad-2e32f760295f for PackagedProductDefinition 783653e6-648c-4600-85dd-8109255179d2

Reimbursement SL 8e609734-8cc7-4cd9-ac23-a68c3d06dbc5 for PackagedProductDefinition 41b3f63e-209c-45a8-8ce1-7cb6e6ba138e

Methylphenidati hydrochloridum

Kinder ab 6 Jahren, Jugendliche und Erwachsene: Diagnosestellung durch einen Facharzt der Kinder- und Jugendmedizin mit Schwerpunkt Entwicklungspädiatrie oder einen Facharzt der Psychiatrie und Psychotherapie, Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen, Behandlung im Rahmen eines umfassenden Therapieprogramms, Bei Erwachsenen müssen entsprechende Symptome bereits in der Kindheit bestanden haben.


Marketing Authorisation 69315 for MedicinalProductDefinition 2fafcfc6-74c0-4f24-beab-e006bf8d1033

Methylphenidat Spirig HC Ret Tabl 54 mg Ds 30 Stk

Methylphenidat Spirig HC Ret Tabl 54 mg Ds 60 Stk

Marketing Authorisation 69315007-fd7d24bd-6541-4499-9c8f-0305391252c3 for PackagedProductDefinition fd7d24bd-6541-4499-9c8f-0305391252c3

Marketing Authorisation 69315008-72de8f4f-f5ac-422d-b3af-ecc5bc600b48 for PackagedProductDefinition 72de8f4f-f5ac-422d-b3af-ecc5bc600b48

Reimbursement SL ab8a1a5d-638e-4860-9df5-7976dbdf84a9 for PackagedProductDefinition fd7d24bd-6541-4499-9c8f-0305391252c3

Reimbursement SL a7ff97e0-c720-4748-a658-d2b57dcec65d for PackagedProductDefinition 72de8f4f-f5ac-422d-b3af-ecc5bc600b48

Methylphenidati hydrochloridum


Folsäure (Calcium folinat siehe V03AF03)

Marketing Authorisation 65228 for MedicinalProductDefinition 60369e56-68d1-4a02-8e0c-16fb00ed39f4

Metofol Tabl 5 mg 100 Stk

Marketing Authorisation 65228002-09e408fc-3dd0-40f9-b70f-839491bc59c6 for PackagedProductDefinition 09e408fc-3dd0-40f9-b70f-839491bc59c6

Reimbursement SL 76ecdb48-0fdd-4d49-9a8c-2c8ab548c898 for PackagedProductDefinition 09e408fc-3dd0-40f9-b70f-839491bc59c6

Acidum folicum


Marketing Authorisation 57272 for MedicinalProductDefinition 26471784-a0ec-4a9b-9c1f-eb91220c8d79

Metoject Inj Lös 7.5 mg / 0.15 ml Fertigspr 0.15 ml

Marketing Authorisation 57272040-2386ef8b-ce30-41ca-a6b8-838297432094 for PackagedProductDefinition 2386ef8b-ce30-41ca-a6b8-838297432094

Reimbursement SL 7c9328cb-fbbb-4b78-bae4-25fd3c50f8ea for PackagedProductDefinition 2386ef8b-ce30-41ca-a6b8-838297432094

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition 0d8e4660-71f9-4d9f-8087-b8256977058a

Metoject Inj Lös 10 mg / 0.2 ml Fertigspr 0.2 ml

Marketing Authorisation 57272044-35ce1803-ad29-46d6-a6da-6f341b4cea5c for PackagedProductDefinition 35ce1803-ad29-46d6-a6da-6f341b4cea5c

Reimbursement SL ce63a991-424f-497e-80ee-ae955cbd1451 for PackagedProductDefinition 35ce1803-ad29-46d6-a6da-6f341b4cea5c

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition 1b957b7d-f03c-4f4b-a9d8-5495389a13e3

Metoject Inj Lös 12.5 mg / 0.25 ml Fertigspr 0.25 ml

Marketing Authorisation 57272085-f6c667d6-75a7-4f80-beaf-a3a664d74c73 for PackagedProductDefinition f6c667d6-75a7-4f80-beaf-a3a664d74c73

Reimbursement SL 3e9a06ec-e444-40e1-8abd-e502785af04d for PackagedProductDefinition f6c667d6-75a7-4f80-beaf-a3a664d74c73

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition 51789f22-d786-4ea7-9461-a0286cf0bbe2

Metoject Inj Lös 15 mg / 0.3 ml Fertigspr 0.3 ml

Marketing Authorisation 57272048-1ec66062-8896-4c6e-8f3b-28fcf9c3cc47 for PackagedProductDefinition 1ec66062-8896-4c6e-8f3b-28fcf9c3cc47

Reimbursement SL 96a79031-76e3-4dfc-a0bd-c4ef36c6b1b4 for PackagedProductDefinition 1ec66062-8896-4c6e-8f3b-28fcf9c3cc47

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition 1ea23dab-bfb8-4efa-aa67-ff118f713ce9

Metoject Inj Lös 17.5 mg / 0.35 ml Fertigspr 0.35 ml

Marketing Authorisation 57272090-7809fdae-aae0-4fae-a87a-7c861c1815ec for PackagedProductDefinition 7809fdae-aae0-4fae-a87a-7c861c1815ec

Reimbursement SL 988bcda0-2b6a-4a53-b301-bc47532b2f0a for PackagedProductDefinition 7809fdae-aae0-4fae-a87a-7c861c1815ec

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition ea1a072c-5792-402b-a134-f3b82fae498c

Metoject Inj Lös 20 mg / 0.4 ml Fertigspr 0.4 ml

Marketing Authorisation 57272052-3d19195a-ea96-451b-8932-c47323ff5ef9 for PackagedProductDefinition 3d19195a-ea96-451b-8932-c47323ff5ef9

Reimbursement SL ddf37038-33f3-45c9-b045-60ad2c225ea0 for PackagedProductDefinition 3d19195a-ea96-451b-8932-c47323ff5ef9

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition dededb03-b824-4e03-9407-d7b239cd331d

Metoject Inj Lös 22.5 mg / 0.45 ml Fertigspr 0.45 ml

Marketing Authorisation 57272095-65e27515-0309-4ebc-993f-efe31c3bc45a for PackagedProductDefinition 65e27515-0309-4ebc-993f-efe31c3bc45a

Reimbursement SL 4ce4b1d0-2b6e-4529-9745-902e1d7800af for PackagedProductDefinition 65e27515-0309-4ebc-993f-efe31c3bc45a

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition 960b15c2-3b4c-4906-947b-232bd6fbf322

Metoject Inj Lös 25 mg / 0.5 ml Fertigspr 0.5 ml

Marketing Authorisation 57272056-b7fa6c9d-6607-4b5b-8b99-7bea791eec3a for PackagedProductDefinition b7fa6c9d-6607-4b5b-8b99-7bea791eec3a

Reimbursement SL 6e5274c1-24a0-49e4-8585-b4c868ec04c0 for PackagedProductDefinition b7fa6c9d-6607-4b5b-8b99-7bea791eec3a

Methotrexatum


Marketing Authorisation 57272 for MedicinalProductDefinition 2de24be1-7928-453e-b184-77d870c68473

Metoject Inj Lös 30 mg / 0.6 ml Fertigspr 0.6 ml

Reimbursement SL 427d3348-a9ab-4676-ab33-f19aafc8f24b for PackagedProductDefinition b3f78168-0792-4fe8-b148-766611292ff1

Methotrexatum


Metoject auto-injecteur sol inj 7.5 mg / 0.15 ml

Marketing Authorisation 65672 for MedicinalProductDefinition a85d94c1-77aa-4b82-94ba-eaf077ce2de3

Metoject Autoinjektor Inj Lös 7.5 mg / 0.15 ml Fertpen 1 Stk

Reimbursement SL 844b8fdd-9605-4bcc-9cae-403576ee6219 for PackagedProductDefinition 8797da4a-9295-4132-a372-900385b4f68e

Methotrexatum


Metoject auto-injecteur sol inj 10 mg / 0.2 ml

Marketing Authorisation 65672 for MedicinalProductDefinition 12c05643-accd-4037-a3ed-b2e62314a66f

Metoject Autoinjektor Inj Lös 10 mg / 0.2 ml Fertpen 1 Stk

Marketing Authorisation 65672106-ebf80317-dfd1-4c4a-a42e-c565cc1cb9d6 for PackagedProductDefinition ebf80317-dfd1-4c4a-a42e-c565cc1cb9d6

Reimbursement SL 4e577461-8227-4de9-8e5c-3a644838afa8 for PackagedProductDefinition ebf80317-dfd1-4c4a-a42e-c565cc1cb9d6

Methotrexatum


Metoject auto-injecteur sol inj 12.5 mg / 0.25 ml

Marketing Authorisation 65672 for MedicinalProductDefinition 057ccedc-a533-4aa2-bb01-9e8bddbd3d75

Metoject Autoinjektor Inj Lös 12.5 mg / 0.25 ml Fertpen 1 Stk

Marketing Authorisation 65672111-b225d33d-db4c-40dc-8e21-8e63cc83b999 for PackagedProductDefinition b225d33d-db4c-40dc-8e21-8e63cc83b999

Reimbursement SL 87f6783e-5bee-430f-ad35-e6db5d7cc008 for PackagedProductDefinition b225d33d-db4c-40dc-8e21-8e63cc83b999

Methotrexatum


Metoject auto-injecteur sol inj 15 mg / 0.3 ml

Marketing Authorisation 65672 for MedicinalProductDefinition c150da52-b3d8-4286-90dd-63f6dfc7d0f0

Metoject Autoinjektor Inj Lös 15 mg / 0.3 ml Fertpen 1 Stk

Marketing Authorisation 65672116-41438cc3-c1d1-45bc-beed-3bcb15e29182 for PackagedProductDefinition 41438cc3-c1d1-45bc-beed-3bcb15e29182

Reimbursement SL b97d4b49-30c5-4ef6-9cb0-ce82ee4a56d8 for PackagedProductDefinition 41438cc3-c1d1-45bc-beed-3bcb15e29182

Methotrexatum


Metoject auto-injecteur sol inj 17.5 mg / 0.35 ml

Marketing Authorisation 65672 for MedicinalProductDefinition ec61a526-3f48-4a41-a0ee-ebc8d9a4fcd3

Metoject Autoinjektor Inj Lös 17.5 mg / 0.35 ml Fertpen 1 Stk

Marketing Authorisation 65672121-94cf3e81-974e-4ced-96fd-8d25330a3825 for PackagedProductDefinition 94cf3e81-974e-4ced-96fd-8d25330a3825

Reimbursement SL 6eec2d97-7937-439a-8424-470a1be6ef1d for PackagedProductDefinition 94cf3e81-974e-4ced-96fd-8d25330a3825

Methotrexatum


Metoject auto-injecteur sol inj 20 mg / 0.4 ml

Marketing Authorisation 65672 for MedicinalProductDefinition 7ab52b82-ae38-4bb5-9a67-68ab062033cb

Metoject Autoinjektor Inj Lös 20 mg / 0.4 ml Fertpen 1 Stk

Marketing Authorisation 65672126-1a89f798-d869-4b0c-9ae7-a11cf825dcf2 for PackagedProductDefinition 1a89f798-d869-4b0c-9ae7-a11cf825dcf2

Reimbursement SL 7d1b6791-a3d9-493c-8181-901bed360480 for PackagedProductDefinition 1a89f798-d869-4b0c-9ae7-a11cf825dcf2

Methotrexatum


Metoject auto-injecteur sol inj 22.5 mg / 0.45 ml

Marketing Authorisation 65672 for MedicinalProductDefinition 3be654a4-217f-4dd8-8838-96c5dff2f56c

Metoject Autoinjektor Inj Lös 22.5 mg / 0.45 ml Fertpen 1 Stk

Marketing Authorisation 65672131-a5af6e18-bb16-4ab8-9eb3-99b4b987927e for PackagedProductDefinition a5af6e18-bb16-4ab8-9eb3-99b4b987927e

Reimbursement SL 92a0df51-9543-4646-a96c-2ad1f839b9fd for PackagedProductDefinition a5af6e18-bb16-4ab8-9eb3-99b4b987927e

Methotrexatum


Metoject auto-injecteur sol inj 25 mg / 0.5 ml

Marketing Authorisation 65672 for MedicinalProductDefinition d078b90b-7206-4725-8347-60e2dc21cf62

Metoject Autoinjektor Inj Lös 25 mg / 0.5 ml Fertpen 1 Stk

Marketing Authorisation 65672136-3b3fec4e-e2c8-4163-b273-4499b3e3b747 for PackagedProductDefinition 3b3fec4e-e2c8-4163-b273-4499b3e3b747

Reimbursement SL 8a6ff59a-65fa-4e68-9ca7-2e64ec4be0ff for PackagedProductDefinition 3b3fec4e-e2c8-4163-b273-4499b3e3b747

Methotrexatum


Marketing Authorisation 56468 for MedicinalProductDefinition 616e3312-79a7-4de5-8511-2a633721a1f1

Metolazon Galepharm Tabl 5 mg 20 Stk

Metolazon Galepharm Tabl 5 mg 100 Stk

Marketing Authorisation 56468001-68b7bf73-8171-4e1e-928f-49f0b801dfad for PackagedProductDefinition 68b7bf73-8171-4e1e-928f-49f0b801dfad

Marketing Authorisation 56468002-09ee7d83-b6a2-4f5c-8cdd-0f5acec3f00f for PackagedProductDefinition 09ee7d83-b6a2-4f5c-8cdd-0f5acec3f00f

Reimbursement SL 18f68e1d-2e80-4b89-b67e-947dba636044 for PackagedProductDefinition 68b7bf73-8171-4e1e-928f-49f0b801dfad

Reimbursement SL b7fbe4de-ece3-4e63-81ca-690f4478eb5b for PackagedProductDefinition 09ee7d83-b6a2-4f5c-8cdd-0f5acec3f00f

Metolazonum


Marketing Authorisation 27867 for MedicinalProductDefinition 4de211d1-bfa2-4081-884e-8a95db146e9e

Metopiron 250 Kaps 250 mg 50 Stk

Marketing Authorisation 27867014-2a1e2130-5ec1-4330-8042-ede738b2f52e for PackagedProductDefinition 2a1e2130-5ec1-4330-8042-ede738b2f52e

Reimbursement SL a2478d58-0b6a-4589-a369-6bf2138b4289 for PackagedProductDefinition 2a1e2130-5ec1-4330-8042-ede738b2f52e

Metyraponum

Zur Behandlung des Cushing-Syndroms bei nicht diagnostizierbarer Ursache des Hypercortisolismus, bei transitorisch oder persistierend inoperablen Patienten oder in Kombination mit einer Strahlentherapie.


Marketing Authorisation 65958 for MedicinalProductDefinition 4cf4987b-cf85-417c-b7f8-f3138b103675

Metoprolol axapharm Ret Tabl 25 mg 30 Stk

Metoprolol axapharm Ret Tabl 25 mg 100 Stk

Marketing Authorisation 65958001-f1fd8c33-9079-4668-9e65-2b83315b085d for PackagedProductDefinition f1fd8c33-9079-4668-9e65-2b83315b085d

Marketing Authorisation 65958003-c262cf06-890f-4230-a623-238e1958b1da for PackagedProductDefinition c262cf06-890f-4230-a623-238e1958b1da

Reimbursement SL a44c9d38-7fc1-4730-856d-06c03cc916ad for PackagedProductDefinition f1fd8c33-9079-4668-9e65-2b83315b085d

Reimbursement SL 5993d862-bfad-4647-b44f-9c991ef93919 for PackagedProductDefinition c262cf06-890f-4230-a623-238e1958b1da

Metoprololi tartras (2:1)


Marketing Authorisation 65958 for MedicinalProductDefinition f4592947-6f88-4af3-a94e-badf041e5cd6

Metoprolol axapharm Ret Tabl 50 mg 30 Stk

Metoprolol axapharm Ret Tabl 50 mg 100 Stk

Marketing Authorisation 65958004-cc444afe-35ed-4ea0-b3d0-35608b44fcbd for PackagedProductDefinition cc444afe-35ed-4ea0-b3d0-35608b44fcbd

Marketing Authorisation 65958006-e556bc18-e5a5-4742-a388-5382da21bfb3 for PackagedProductDefinition e556bc18-e5a5-4742-a388-5382da21bfb3

Reimbursement SL 11fa8261-184e-4e4c-83bc-ac0c104a43ed for PackagedProductDefinition cc444afe-35ed-4ea0-b3d0-35608b44fcbd

Reimbursement SL 88765364-5f82-41fb-bbfe-5ba55be206b9 for PackagedProductDefinition e556bc18-e5a5-4742-a388-5382da21bfb3

Metoprololi tartras (2:1)


Marketing Authorisation 65958 for MedicinalProductDefinition d6387ace-a109-4a42-a0ab-52a26bf17e91

Metoprolol axapharm Ret Tabl 100 mg 30 Stk

Metoprolol axapharm Ret Tabl 100 mg 100 Stk

Marketing Authorisation 65958007-afd95e70-a48b-4967-ba5b-e3ecbd0f5e2b for PackagedProductDefinition afd95e70-a48b-4967-ba5b-e3ecbd0f5e2b

Marketing Authorisation 65958009-3a8962f0-d5e2-4f60-b680-dc14c8969bc3 for PackagedProductDefinition 3a8962f0-d5e2-4f60-b680-dc14c8969bc3

Reimbursement SL 39dc2d56-7543-407e-8e8f-e415c7d03c25 for PackagedProductDefinition afd95e70-a48b-4967-ba5b-e3ecbd0f5e2b

Reimbursement SL 911adb95-56ce-4aca-aac2-193bc4029ad8 for PackagedProductDefinition 3a8962f0-d5e2-4f60-b680-dc14c8969bc3

Metoprololi tartras (2:1)


Marketing Authorisation 65958 for MedicinalProductDefinition 05e93f28-c86e-4733-91c0-3669cd535880

Metoprolol axapharm Ret Tabl 200 mg 30 Stk

Metoprolol axapharm Ret Tabl 200 mg 100 Stk

Marketing Authorisation 65958010-5faca4f9-599f-4d95-b70d-5f85f63efa6b for PackagedProductDefinition 5faca4f9-599f-4d95-b70d-5f85f63efa6b

Marketing Authorisation 65958012-6b4d4f61-e776-47fa-b255-fbcbe6f42bf2 for PackagedProductDefinition 6b4d4f61-e776-47fa-b255-fbcbe6f42bf2

Reimbursement SL e8c1a9e3-34ea-4177-8084-710fe3b00d59 for PackagedProductDefinition 5faca4f9-599f-4d95-b70d-5f85f63efa6b

Reimbursement SL afa13e5d-870c-4666-b327-3a5cf501775f for PackagedProductDefinition 6b4d4f61-e776-47fa-b255-fbcbe6f42bf2

Metoprololi tartras (2:1)


Marketing Authorisation 66159 for MedicinalProductDefinition ff3ee01b-3182-4dc8-bcf6-26e14a1dc6ba

Metoprolol-Mepha Depotabs 25 mg 30 Stk

Metoprolol-Mepha Depotabs 25 mg 100 Stk

Marketing Authorisation 66159001-0911a44b-5634-4c13-ace6-1d27014d1509 for PackagedProductDefinition 0911a44b-5634-4c13-ace6-1d27014d1509

Marketing Authorisation 66159003-3677602c-041c-476f-a8ee-3ddf92e1c3a6 for PackagedProductDefinition 3677602c-041c-476f-a8ee-3ddf92e1c3a6

Reimbursement SL 388aeb00-f0b8-42a4-beaa-a710236126de for PackagedProductDefinition 0911a44b-5634-4c13-ace6-1d27014d1509

Reimbursement SL 4c67cdb5-fe3a-4c90-a2d9-b3a15d8cf02d for PackagedProductDefinition 3677602c-041c-476f-a8ee-3ddf92e1c3a6

Metoprololi tartras (2:1)


Marketing Authorisation 66159 for MedicinalProductDefinition 5a4c77d0-c79d-47d8-888d-bd5db5743af2

Metoprolol-Mepha Depotabs 50 mg 30 Stk

Metoprolol-Mepha Depotabs 50 mg 100 Stk

Marketing Authorisation 66159004-2c5a9340-8aa6-4664-a305-7c654eec25c8 for PackagedProductDefinition 2c5a9340-8aa6-4664-a305-7c654eec25c8

Marketing Authorisation 66159006-63183e0a-049e-43d8-a057-3fb27507d483 for PackagedProductDefinition 63183e0a-049e-43d8-a057-3fb27507d483

Reimbursement SL 1c6d7f67-cd0d-4a8c-a365-539da33c0511 for PackagedProductDefinition 2c5a9340-8aa6-4664-a305-7c654eec25c8

Reimbursement SL 702057c9-a9c6-4a17-a54f-9659aa54a90c for PackagedProductDefinition 63183e0a-049e-43d8-a057-3fb27507d483

Metoprololi tartras (2:1)


Marketing Authorisation 66159 for MedicinalProductDefinition 56ccc183-0ef4-468a-9b4b-dd5ab6c802a0

Metoprolol-Mepha Depotabs 100 mg 30 Stk

Metoprolol-Mepha Depotabs 100 mg 100 Stk

Marketing Authorisation 66159007-752c78e6-d3eb-47f6-8eff-d65a0e723685 for PackagedProductDefinition 752c78e6-d3eb-47f6-8eff-d65a0e723685

Marketing Authorisation 66159009-f3c73b62-94d8-443d-9cc7-44f6620a0b90 for PackagedProductDefinition f3c73b62-94d8-443d-9cc7-44f6620a0b90

Reimbursement SL ae1d3ce8-efc7-4f1c-bab8-05594c6c63fe for PackagedProductDefinition 752c78e6-d3eb-47f6-8eff-d65a0e723685

Reimbursement SL 36188a9a-d27a-40db-9c77-0a70d69fcb73 for PackagedProductDefinition f3c73b62-94d8-443d-9cc7-44f6620a0b90

Metoprololi tartras (2:1)


Marketing Authorisation 66159 for MedicinalProductDefinition a5bba363-d5fc-4357-baad-b7f0abb8a86b

Metoprolol-Mepha Depotabs 200 mg 30 Stk

Metoprolol-Mepha Depotabs 200 mg 100 Stk

Marketing Authorisation 66159010-cf01ea36-d22f-482b-b655-570b856e58f7 for PackagedProductDefinition cf01ea36-d22f-482b-b655-570b856e58f7

Marketing Authorisation 66159012-d4bea76a-1687-4aee-acb2-b2e445037c3c for PackagedProductDefinition d4bea76a-1687-4aee-acb2-b2e445037c3c

Reimbursement SL dc5c096a-19d3-43d3-8882-a0b0b1e7af8f for PackagedProductDefinition cf01ea36-d22f-482b-b655-570b856e58f7

Reimbursement SL d33c3332-f083-42c5-b947-3141df1ed67b for PackagedProductDefinition d4bea76a-1687-4aee-acb2-b2e445037c3c

Metoprololi tartras (2:1)


Marketing Authorisation 65908 for MedicinalProductDefinition 528d1ecb-0c08-4282-92c0-b01792a36efe

Metoprolol Spirig HC Ret Filmtabl 25 mg 30 Stk

Metoprolol Spirig HC Ret Filmtabl 25 mg 100 Stk

Marketing Authorisation 65908001-9a186eee-33d1-466a-9ae3-12a368ea82c0 for PackagedProductDefinition 9a186eee-33d1-466a-9ae3-12a368ea82c0

Marketing Authorisation 65908003-41a7523d-b468-4d0b-b3bc-8bd857155fa9 for PackagedProductDefinition 41a7523d-b468-4d0b-b3bc-8bd857155fa9

Reimbursement SL dd86ff91-309d-4f1a-bf2f-dff4b7f3a933 for PackagedProductDefinition 9a186eee-33d1-466a-9ae3-12a368ea82c0

Reimbursement SL 8db00336-620a-4005-971b-fdf05ca2fcc7 for PackagedProductDefinition 41a7523d-b468-4d0b-b3bc-8bd857155fa9

Metoprololi tartras (2:1)


Marketing Authorisation 65908 for MedicinalProductDefinition b900f006-7ea5-4998-9c32-ee7e58c77bd4

Metoprolol Spirig HC Ret Filmtabl 50 mg 30 Stk

Metoprolol Spirig HC Ret Filmtabl 50 mg 100 Stk

Marketing Authorisation 65908004-24e439f5-50e2-4456-a707-b1fcc9017914 for PackagedProductDefinition 24e439f5-50e2-4456-a707-b1fcc9017914

Marketing Authorisation 65908006-2eaff991-b631-4886-a799-c9b7a16fb42b for PackagedProductDefinition 2eaff991-b631-4886-a799-c9b7a16fb42b

Reimbursement SL f2afbab3-5432-41c5-8973-5a1a52e3c78b for PackagedProductDefinition 24e439f5-50e2-4456-a707-b1fcc9017914

Reimbursement SL 5fe5d978-9b80-4f9e-abd0-382346e57519 for PackagedProductDefinition 2eaff991-b631-4886-a799-c9b7a16fb42b

Metoprololi tartras (2:1)


Métoprolol Spirig HC cpr pell ret 100 mg

Marketing Authorisation 65908 for MedicinalProductDefinition f7a5d983-ef26-4f47-99ad-994d468a8357

Metoprolol Spirig HC Ret Filmtabl 100 mg 30 Stk

Metoprolol Spirig HC Ret Filmtabl 100 mg 100 Stk

Marketing Authorisation 65908007-07c0071b-6ca7-497f-92c3-08fd8b3c2de1 for PackagedProductDefinition 07c0071b-6ca7-497f-92c3-08fd8b3c2de1

Marketing Authorisation 65908009-bd610f75-27d7-4819-b9c0-3d40bd6c6a5b for PackagedProductDefinition bd610f75-27d7-4819-b9c0-3d40bd6c6a5b

Reimbursement SL 88a73c4b-55d9-401e-ae5e-4cd4bbc067e9 for PackagedProductDefinition 07c0071b-6ca7-497f-92c3-08fd8b3c2de1

Reimbursement SL f4888add-45a4-4b1b-8d8c-a5487464a38c for PackagedProductDefinition bd610f75-27d7-4819-b9c0-3d40bd6c6a5b

Metoprololi tartras (2:1)


Métoprolol Spirig HC cpr pell ret 200 mg

Marketing Authorisation 65908 for MedicinalProductDefinition 9b9e51ac-4dff-4579-a4e5-8ea6cd171f7a

Metoprolol Spirig HC Ret Filmtabl 200 mg 30 Stk

Metoprolol Spirig HC Ret Filmtabl 200 mg 100 Stk

Marketing Authorisation 65908010-b318f954-ba3f-4c64-ad41-1432f25fd1ca for PackagedProductDefinition b318f954-ba3f-4c64-ad41-1432f25fd1ca

Marketing Authorisation 65908012-8e4536e2-e89c-4208-a3f4-6701ab4a54e8 for PackagedProductDefinition 8e4536e2-e89c-4208-a3f4-6701ab4a54e8

Reimbursement SL b26de742-71db-4e8a-a09b-aeacbe98c5b6 for PackagedProductDefinition b318f954-ba3f-4c64-ad41-1432f25fd1ca

Reimbursement SL 4154f5b1-6833-4b9c-85b4-6e3898713509 for PackagedProductDefinition 8e4536e2-e89c-4208-a3f4-6701ab4a54e8

Metoprololi tartras (2:1)


Marketing Authorisation 56969 for MedicinalProductDefinition 26b0ac0f-acd7-471e-a276-1041fbdd28e1

Meto Zerok Ret Tabl 25 mg 30 Stk

Meto Zerok Ret Tabl 25 mg 100 Stk

Marketing Authorisation 56969014-1993786a-53ff-4546-bdf0-6350bf95050d for PackagedProductDefinition 1993786a-53ff-4546-bdf0-6350bf95050d

Marketing Authorisation 56969016-9c4a35c3-a381-40b5-8b93-572bbbe5e031 for PackagedProductDefinition 9c4a35c3-a381-40b5-8b93-572bbbe5e031

Reimbursement SL 9a18cc2c-ac39-4064-a980-f41f1e51ce9c for PackagedProductDefinition 1993786a-53ff-4546-bdf0-6350bf95050d

Reimbursement SL 8de90891-7fb6-4c93-b784-862db0d19582 for PackagedProductDefinition 9c4a35c3-a381-40b5-8b93-572bbbe5e031

Metoprololi tartras (2:1)


Marketing Authorisation 56969 for MedicinalProductDefinition c7c4ab8f-28ce-481e-8de5-3c3e4953409d

Meto Zerok Ret Tabl 50 mg 30 Stk

Meto Zerok Ret Tabl 50 mg 100 Stk

Marketing Authorisation 56969002-74cbc410-f474-4f43-9443-d5e236bb1863 for PackagedProductDefinition 74cbc410-f474-4f43-9443-d5e236bb1863

Marketing Authorisation 56969004-bf89396c-4ec3-4fe9-be2a-6fcd3112dcaf for PackagedProductDefinition bf89396c-4ec3-4fe9-be2a-6fcd3112dcaf

Reimbursement SL 5ce9ed43-0027-4a3f-857e-4d84e9328555 for PackagedProductDefinition 74cbc410-f474-4f43-9443-d5e236bb1863

Reimbursement SL ad804efe-ef00-451d-be87-ba4a52ba1ec2 for PackagedProductDefinition bf89396c-4ec3-4fe9-be2a-6fcd3112dcaf

Metoprololi tartras (2:1)


Marketing Authorisation 56969 for MedicinalProductDefinition 93768bbb-ea59-4491-8366-3cfd696b0a5e

Meto Zerok Ret Tabl 100 mg 30 Stk

Meto Zerok Ret Tabl 100 mg 100 Stk

Marketing Authorisation 56969006-1a715fd2-d31c-4b2f-bb74-44dab5ee72ae for PackagedProductDefinition 1a715fd2-d31c-4b2f-bb74-44dab5ee72ae

Marketing Authorisation 56969008-6d9f9825-e8f0-420e-b9f1-6242225e45ad for PackagedProductDefinition 6d9f9825-e8f0-420e-b9f1-6242225e45ad

Reimbursement SL 69531ee1-896d-4e7e-bb95-4786d077d98d for PackagedProductDefinition 1a715fd2-d31c-4b2f-bb74-44dab5ee72ae

Reimbursement SL 88954c57-52bd-4f7d-9a5c-8aa84f1a9341 for PackagedProductDefinition 6d9f9825-e8f0-420e-b9f1-6242225e45ad

Metoprololi tartras (2:1)


Marketing Authorisation 56969 for MedicinalProductDefinition 51860bf9-cb23-4823-944a-dd83771e8fcb

Meto Zerok Ret Tabl 200 mg 30 Stk

Meto Zerok Ret Tabl 200 mg 100 Stk

Marketing Authorisation 56969010-e916fa15-5088-4f9a-b59c-e232688c7abc for PackagedProductDefinition e916fa15-5088-4f9a-b59c-e232688c7abc

Marketing Authorisation 56969012-869461dc-a842-469b-aab6-16ca70893514 for PackagedProductDefinition 869461dc-a842-469b-aab6-16ca70893514

Reimbursement SL 8aaed4d1-98c2-4ac2-8b13-983ecfba3829 for PackagedProductDefinition e916fa15-5088-4f9a-b59c-e232688c7abc

Reimbursement SL 80e39d7d-8e42-456b-814c-2aae076462ab for PackagedProductDefinition 869461dc-a842-469b-aab6-16ca70893514

Metoprololi tartras (2:1)


Marketing Authorisation 67683 for MedicinalProductDefinition 27dc35a2-dc36-4da8-96d6-640da44c97f0

Metrissa Filmtabl 2 mg Blist 28 Stk

Metrissa Filmtabl 2 mg 3 Blist 28 Stk

Marketing Authorisation 67683004-7d427fe8-a191-4137-91e7-8d3588e07b76 for PackagedProductDefinition 7d427fe8-a191-4137-91e7-8d3588e07b76

Marketing Authorisation 67683005-6eec8c99-d996-4cdb-83e3-9a0bdb7247fc for PackagedProductDefinition 6eec8c99-d996-4cdb-83e3-9a0bdb7247fc

Reimbursement SL 3acb8786-cbda-4df7-a15f-bb87b06f4ae6 for PackagedProductDefinition 7d427fe8-a191-4137-91e7-8d3588e07b76

Reimbursement SL 389f99a5-c280-4e37-a90b-1c691ed4b228 for PackagedProductDefinition 6eec8c99-d996-4cdb-83e3-9a0bdb7247fc

Dienogestum


Marketing Authorisation 40215 for MedicinalProductDefinition 5fd8c446-02e7-4cb9-aa17-871b89568106

Metrolag Tabl 250 mg 20 Stk

Marketing Authorisation 40215069-5ba0a193-9865-46a8-b9c4-8ad295eab091 for PackagedProductDefinition 5ba0a193-9865-46a8-b9c4-8ad295eab091

Reimbursement SL 1f1487ad-3e17-4505-a822-a586a2381355 for PackagedProductDefinition 5ba0a193-9865-46a8-b9c4-8ad295eab091

Metronidazolum


Marketing Authorisation 40215 for MedicinalProductDefinition b3663d89-061e-452c-821e-20b7d173f8d3

Metrolag Tabl 500 mg 8 Stk

Metrolag Tabl 500 mg 24 Stk

Marketing Authorisation 40215042-e7bad890-a2b8-4d8e-8b6d-2844fc32a046 for PackagedProductDefinition e7bad890-a2b8-4d8e-8b6d-2844fc32a046

Reimbursement SL f7a43a3c-7d98-4845-a942-26364fa6dc6c for PackagedProductDefinition e7bad890-a2b8-4d8e-8b6d-2844fc32a046

Reimbursement SL fa9faf94-057f-4975-bb55-b749da0053c8 for PackagedProductDefinition e306b748-7773-4355-807d-c3cd9e575031

Metronidazolum


Marketing Authorisation 62276 for MedicinalProductDefinition 5fccbac4-1db9-4f48-b887-ef7e06a18056

Metronidazole Zentiva Ovula 500 mg 10 Stk

Marketing Authorisation 62276002-02220a5b-dede-449e-9983-2573398847ff for PackagedProductDefinition 02220a5b-dede-449e-9983-2573398847ff

Reimbursement SL ed793a2e-7e2e-427f-b965-3f615ae9f736 for PackagedProductDefinition 02220a5b-dede-449e-9983-2573398847ff

Metronidazolum


Marketing Authorisation 62275 for MedicinalProductDefinition e1bbcd6a-bc3f-4212-9f61-20d21b8358c7

Metronidazol Zentiva Filmtabl 250 mg 20 Stk

Marketing Authorisation 62275001-8697c3b9-7f4d-4430-a1c9-2163922106cb for PackagedProductDefinition 8697c3b9-7f4d-4430-a1c9-2163922106cb

Reimbursement SL 4379cb67-ba95-4b68-b885-ced529043d7f for PackagedProductDefinition 8697c3b9-7f4d-4430-a1c9-2163922106cb

Metronidazolum


Marketing Authorisation 62275 for MedicinalProductDefinition 88e78cc2-070a-4011-abb7-bfbd668b1ddd

Metronidazol Zentiva Filmtabl 500 mg 20 Stk

Reimbursement SL 68f27a44-e905-4036-a6f2-373a4d297fce for PackagedProductDefinition 98d6137c-28c3-42d3-9078-6b33f90610a3

Metronidazolum


Metronidazole Zentiva Tricho cpr pell 500 mg

Marketing Authorisation 62275 for MedicinalProductDefinition bd1eb224-388e-46fd-a59a-ea6875e335bf

Metronidazol Zentiva Tricho Filmtabl 500 mg 4 Stk

Marketing Authorisation 62275002-92d63d6b-9336-48b0-ae78-8e3303de9ef3 for PackagedProductDefinition 92d63d6b-9336-48b0-ae78-8e3303de9ef3

Reimbursement SL 4bdd69cf-1eca-47a0-a8c7-92ae5264f8bc for PackagedProductDefinition 92d63d6b-9336-48b0-ae78-8e3303de9ef3

Metronidazolum


Marketing Authorisation 56134 for MedicinalProductDefinition 896ceafe-442b-49fa-a22e-9d6c76808222

Metvix Creme Tb 2 g

Marketing Authorisation 56134001-74341646-b3ef-4ffe-9592-c5fbeacf3f6a for PackagedProductDefinition 74341646-b3ef-4ffe-9592-c5fbeacf3f6a

Reimbursement SL 9dda06d9-7d43-41a4-82ee-0235611f8602 for PackagedProductDefinition 74341646-b3ef-4ffe-9592-c5fbeacf3f6a

Methylis aminolevulinas


Marketing Authorisation a3dadd65-bf5e-4bae-bdfa-c19c09e0fed7 for MedicinalProductDefinition 521ffc5c-80aa-41dd-8049-0facb5a9da77

Mevalia PKU Balance 1+ Ds 500 g

Marketing Authorisation 35e27fb2-4777-4d92-9053-19010d7d3873 for PackagedProductDefinition 97f9365b-4b7b-4309-b243-349ce5a7c799

Reimbursement SL 58f8e765-c51c-4d8f-8975-fa18f5340ec6 for PackagedProductDefinition 97f9365b-4b7b-4309-b243-349ce5a7c799

Carbohydrata

Proteina

Aminoacida

Vitamina

Mineralia

Spurenelemente


Marketing Authorisation 8afb841c-811e-46a9-a712-82c7c1ca7e32 for MedicinalProductDefinition 21d5cfa7-1586-437b-8788-2865a2a027a4

Mevalia PKU Balance 14+ 500 g

Marketing Authorisation 1b3d9db6-40b3-4dac-9f2e-f9cb19e74a51 for PackagedProductDefinition c1cf94b2-4ff5-4077-93f9-abe352bca088

Reimbursement SL e989a5f0-7e14-465c-8875-b8eb207c2d82 for PackagedProductDefinition c1cf94b2-4ff5-4077-93f9-abe352bca088

Carbohydrata

Proteina

Aminoacida

Vitamina

Mineralia

Spurenelemente


Marketing Authorisation bb45727a-c1ae-445f-b142-8d572e5bae18 for MedicinalProductDefinition 345fcc5e-f98d-45c4-907b-dc1b6c3fae05

Mevalia PKU Balance 6+ Ds 500 g

Marketing Authorisation b7f5de9b-0015-4c42-9e8a-d473852b892e for PackagedProductDefinition 2fc0d051-18e6-4093-a30c-2e729238deef

Reimbursement SL fc46770c-6873-4b17-931f-7298cc91bbac for PackagedProductDefinition 2fc0d051-18e6-4093-a30c-2e729238deef

Carbohydrata

Proteina

Aminoacida

Vitamina

Mineralia

Spurenelemente


Marketing Authorisation 8fa6117b-30bf-4eba-b400-9d3be86c9d0f for MedicinalProductDefinition e8ea4011-1494-40ef-9a39-104b102852d0

Mevalia PKU Balance complete 0-1 Ds 500 g

Marketing Authorisation f722a543-2786-4502-917d-248f7f3f035c for PackagedProductDefinition 4994ec60-969f-4c6b-9f79-428d9f00e624

Reimbursement SL 490789d6-8f5a-444b-ab0a-91e6df15cfdf for PackagedProductDefinition 4994ec60-969f-4c6b-9f79-428d9f00e624

Materia crassa

Carbohydrata

Proteina

Aminoacida

Vitamina

Mineralia

Spurenelemente


Marketing Authorisation c71b2106-17e0-4dd7-9a89-a8d4ce4218a3 for MedicinalProductDefinition e0373c8c-820f-4325-88bc-b7c24f9e2c33

Mevalia PKU Balance complete 1+ Ds 500 g

Marketing Authorisation 4e897f3f-6ee1-4655-8fed-9062b6654bb5 for PackagedProductDefinition 211a12d1-465d-43f0-ac80-5d71c2728ac0

Reimbursement SL 9c1b3db8-cb2c-4c20-8e98-7f27c65d59f9 for PackagedProductDefinition 211a12d1-465d-43f0-ac80-5d71c2728ac0

Materia crassa

Carbohydrata

Proteina

Aminoacida

Vitamina

Mineralia

Spurenelemente


Marketing Authorisation 65811 for MedicinalProductDefinition fc58a3de-7778-44ef-8c1c-26ef66a9d89d

Mezavant Ret Tabl 1.2 g 60 Stk

Marketing Authorisation 65811001-aa2504da-b59b-4b68-9f10-d087b118b89f for PackagedProductDefinition aa2504da-b59b-4b68-9f10-d087b118b89f

Reimbursement SL c7ebf2c8-e06c-42d6-94a0-eb0f25f72ef0 for PackagedProductDefinition aa2504da-b59b-4b68-9f10-d087b118b89f

Mesalazinum


Marketing Authorisation 47600 for MedicinalProductDefinition 2c82215f-6707-4e43-9cea-be578ccba80b

Mg5 Granoral Gran 12 mmol Pfirs-Aprik Btl 10 Stk

Mg5 Granoral Gran 12 mmol Pfirs-Aprik Btl 30 Stk

Marketing Authorisation 47600065-b009d937-05e6-4e44-b1ba-ddac491ba2d7 for PackagedProductDefinition b009d937-05e6-4e44-b1ba-ddac491ba2d7

Marketing Authorisation 47600081-11f3e01a-927a-4566-87ad-15a5bda338dc for PackagedProductDefinition 11f3e01a-927a-4566-87ad-15a5bda338dc

Reimbursement SL f54e6ec9-81c9-4ec5-86a6-66ff82d91583 for PackagedProductDefinition b009d937-05e6-4e44-b1ba-ddac491ba2d7

Reimbursement SL 663b1dbe-c8f9-487d-99c7-dd6b6dac67d1 for PackagedProductDefinition 11f3e01a-927a-4566-87ad-15a5bda338dc

Magnesium ionisatum


Marketing Authorisation 46144 for MedicinalProductDefinition 0d3aab96-acbc-4043-9c96-074eccb32fe9

Mg5 Longoral Kautabl 5 mmol Blist 20 Stk

Mg5 Longoral Kautabl 5 mmol Blist 50 Stk

Mg5 Longoral Kautabl 5 mmol Blist 100 Stk

Marketing Authorisation 46144001-e5fd8a6e-3997-400f-859d-ef69c7daf296 for PackagedProductDefinition e5fd8a6e-3997-400f-859d-ef69c7daf296

Marketing Authorisation 46144002-0940925c-f60f-4d0f-a3de-e4d163eb68eb for PackagedProductDefinition 0940925c-f60f-4d0f-a3de-e4d163eb68eb

Marketing Authorisation 46144003-cbd3266e-bb7a-4c79-a02a-7a4018df1cc8 for PackagedProductDefinition cbd3266e-bb7a-4c79-a02a-7a4018df1cc8

Reimbursement SL ca12ac64-a10d-4fdc-b593-902972ebc237 for PackagedProductDefinition e5fd8a6e-3997-400f-859d-ef69c7daf296

Reimbursement SL f9f82e55-0890-4072-83d6-d7fe056bd36d for PackagedProductDefinition 0940925c-f60f-4d0f-a3de-e4d163eb68eb

Reimbursement SL 892b4101-11aa-42a7-b217-66aad0475193 for PackagedProductDefinition cbd3266e-bb7a-4c79-a02a-7a4018df1cc8

Magnesium ionisatum


Marketing Authorisation 49890 for MedicinalProductDefinition 611e3661-2542-4a08-af2c-a257a25690d3

Mg5 Oraleff Brausetabl 30 Stk

Mg5 Oraleff Brausetabl 60 Stk

Marketing Authorisation 49890028-5c1b7f60-5d05-43ae-88e4-f71c0559b452 for PackagedProductDefinition 5c1b7f60-5d05-43ae-88e4-f71c0559b452

Marketing Authorisation 49890036-ea156c96-a0ab-4744-a9b8-486c32dce84f for PackagedProductDefinition ea156c96-a0ab-4744-a9b8-486c32dce84f

Reimbursement SL 5d8d9e0b-f06a-4b23-995d-e75c2aa5f049 for PackagedProductDefinition 5c1b7f60-5d05-43ae-88e4-f71c0559b452

Reimbursement SL 67e63671-f4ca-4c8c-a222-7cf119b3598e for PackagedProductDefinition ea156c96-a0ab-4744-a9b8-486c32dce84f

Magnesium ionisatum


Marketing Authorisation 38605 for MedicinalProductDefinition bcf8905b-5d1a-437c-8cad-6faa4e8f89b2

Miacalcic Inj Lös 100 IE/ml 5 Amp 1 ml

Marketing Authorisation 38605011-c3dcea7b-71ce-437a-a55e-6348cd769bab for PackagedProductDefinition c3dcea7b-71ce-437a-a55e-6348cd769bab

Reimbursement SL 68863430-c231-429b-966f-0307c672d1ee for PackagedProductDefinition c3dcea7b-71ce-437a-a55e-6348cd769bab

Calcitoninum salmonis

Die Behandlungen bedürfen der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes. Zur Osteoporoseprävention bei akutem Knochenschwund aufgrund plötzlicher Immobilisierung wie zum Beispiel bei Patienten mit Osteoporose-Frakturen. Vergütungsdauer maximal 2 Monate. Morbus Paget (Osteitis deformans): Nur bei Patienten, die nicht auf alternative Behandlungen ansprechen oder bei denen alternative Behandlungen ungeeignet sind. Vergütungsdauer 3 Monate. Bei Hyperkalzämie und hyperkalzämische Krisen hervorgerufen durch: - Tumorbedingte Osteolyse bei Knochenmetastasen von Brust-, Lungen- und Nierenkarzinomen, Myelomen und anderen malignen Tumoren; - Hyperparathyreoidismus, Immobilisierung und Vitamin D-Intoxikation, sowohl für die Notfall- als auch für die Langzeit-Behandlung. Bei Algodystrophie oder Sudeck-Syndrom (Neurodystrophische Störungen) aufgrund unterschiedlicher ätiologischer und prädisponierender Faktoren wie posttraumatische schmerzhafte Osteoporose, Re-flexdystrophie, Schulter-Arm-Syndrom, Kausalgie und arzneimittelbedingte neurotrophische Störungen. Vergütungsdauer bis 6 Wochen.


Miacalcic spray nasal spray nasal 200 U/dose

Marketing Authorisation 47473 for MedicinalProductDefinition 33c44117-8d99-4d66-bdee-7e3619e01d14

Miacalcic Nasalspray Nasenspray 200 E/Dosis Fl 1 Stk

Marketing Authorisation 47473002-053df8ff-f524-453f-b46f-eb9c25df86d5 for PackagedProductDefinition 053df8ff-f524-453f-b46f-eb9c25df86d5

Reimbursement SL e858aca9-db05-4eae-8eaa-3e7150cb42df for PackagedProductDefinition 053df8ff-f524-453f-b46f-eb9c25df86d5

Calcitoninum salmonis

Die Behandlungen bedürfen der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes. Osteoporoseprävention: Bei akutem Knochenschwund aufgrund plötzlicher Immobilisierung wie zum Beispiel bei Patienten mit Osteoporose-Frakturen. Vergütungsdauer maximal 3 Monate. Morbus Paget (Osteitis deformans): Nur bei Patienten, die nicht auf alternative Behandlungen ansprechen oder bei denen alternative Behandlungen ungeeignet sind. Vergütungsdauer 3 Monate. Bei Algodystrophie oder Sudeck-Syndrom (Neurodystrophische Störungen): Neurodystrophische Störungen aufgrund unterschiedlicher ätiologischer und prädisponierender Faktoren wie posttraumatische schmerzhafte Osteoporose, Reflexdystrophie, Schulter-Arm-Syndrom, Kausalgie und arzneimittelbedingte neurotrophische Störungen. Vergütungsdauer bis 6 Wochen.


Marketing Authorisation 56732 for MedicinalProductDefinition 92fad9fa-3209-42a3-a37c-ec891734d210

Mianserin-Mepha 30 Lactabs 30 mg 30 Stk

Mianserin-Mepha 30 Lactabs 30 mg 100 Stk

Marketing Authorisation 56732005-5454daec-65af-42c2-8c86-75441d7b9408 for PackagedProductDefinition 5454daec-65af-42c2-8c86-75441d7b9408

Marketing Authorisation 56732011-19cd4f98-5f97-4873-853a-dc81933c5ffb for PackagedProductDefinition 19cd4f98-5f97-4873-853a-dc81933c5ffb

Reimbursement SL 0b639cd4-2034-4ce9-8cc7-2b44b9903e7d for PackagedProductDefinition 5454daec-65af-42c2-8c86-75441d7b9408

Reimbursement SL 122c236f-bb2f-4fa8-9023-baf6aca99a46 for PackagedProductDefinition 19cd4f98-5f97-4873-853a-dc81933c5ffb

Mianserini hydrochloridum


Marketing Authorisation 56732 for MedicinalProductDefinition 955b0a40-15cf-4424-8fc4-1707fc3736e4

Mianserin-Mepha 60 Lactabs 60 mg 30 Stk

Mianserin-Mepha 60 Lactabs 60 mg 100 Stk

Marketing Authorisation 56732017-383f5c63-ff6e-44fc-8f5c-20e698a514cf for PackagedProductDefinition 383f5c63-ff6e-44fc-8f5c-20e698a514cf

Marketing Authorisation 56732023-eb9f8a3c-c870-4203-bfe3-01e056bbbbe1 for PackagedProductDefinition eb9f8a3c-c870-4203-bfe3-01e056bbbbe1

Reimbursement SL 8c903f65-3236-45eb-9808-db8b345cea62 for PackagedProductDefinition 383f5c63-ff6e-44fc-8f5c-20e698a514cf

Reimbursement SL 7e6bb6e5-4d4a-406b-8d62-f5b65201052e for PackagedProductDefinition eb9f8a3c-c870-4203-bfe3-01e056bbbbe1

Mianserini hydrochloridum


Marketing Authorisation 52731 for MedicinalProductDefinition 26a47e23-780f-4321-adc0-21257e3967b2

MIBG I-123 Curium Inj Lös 74 MBq Amp 1 ml

Marketing Authorisation 52731001-9e011af7-c55e-481e-8399-c49d1b4f340b for PackagedProductDefinition 9e011af7-c55e-481e-8399-c49d1b4f340b

Reimbursement SL 78fe13c6-0766-4c5f-919e-407887b8d018 for PackagedProductDefinition 9e011af7-c55e-481e-8399-c49d1b4f340b

Iobenguanum (123I)


Marketing Authorisation 52731 for MedicinalProductDefinition 278addff-189e-4aca-a94e-d419e9faf0d4

MIBG I-123 Curium Inj Lös 148 MBq Amp 2 ml

Marketing Authorisation 52731002-34f1a983-e011-4d2b-b01a-357f545b9acc for PackagedProductDefinition 34f1a983-e011-4d2b-b01a-357f545b9acc

Reimbursement SL de43d102-f0e9-46db-aa41-3041fd42baf0 for PackagedProductDefinition 34f1a983-e011-4d2b-b01a-357f545b9acc

Iobenguanum (123I)


Marketing Authorisation 52731 for MedicinalProductDefinition 10b5f881-db81-41eb-acb6-1a33ee0c851d

MIBG I-123 Curium Inj Lös 222 MBq Amp 3 ml

Marketing Authorisation 52731003-014f287e-7d3b-428e-b842-c00f080c7066 for PackagedProductDefinition 014f287e-7d3b-428e-b842-c00f080c7066

Reimbursement SL b9649b17-1095-45d8-b2d9-974d5fb8232e for PackagedProductDefinition 014f287e-7d3b-428e-b842-c00f080c7066

Iobenguanum (123I)


Marketing Authorisation 52731 for MedicinalProductDefinition daaf6877-19e2-47ef-aa1c-09aacae10a54

MIBG I-123 Curium Inj Lös 370 MBq Amp 5 ml

Marketing Authorisation 52731005-5d5d7d18-30ee-425c-ab6e-251b3b671b89 for PackagedProductDefinition 5d5d7d18-30ee-425c-ab6e-251b3b671b89

Reimbursement SL 8d1b39ea-3faa-4a5f-b868-bfba5c69792e for PackagedProductDefinition 5d5d7d18-30ee-425c-ab6e-251b3b671b89

Iobenguanum (123I)


02.07.10. Einfache blutdrucksenkende Mittel

Marketing Authorisation 54780 for MedicinalProductDefinition 77aaecde-7205-41d4-bb8f-a078f5d69b34

Micardis Tabl 40 mg 28 Stk

Micardis Tabl 40 mg 98 Stk

Marketing Authorisation 54780036-6e9fea91-1126-482c-968c-bf4b3a3dd818 for PackagedProductDefinition 6e9fea91-1126-482c-968c-bf4b3a3dd818

Marketing Authorisation 54780052-fee2773d-ed1e-45b9-8723-b6661f7bf0d5 for PackagedProductDefinition fee2773d-ed1e-45b9-8723-b6661f7bf0d5

Reimbursement SL 688362fb-4453-47ef-b396-b6e95289a3f1 for PackagedProductDefinition 6e9fea91-1126-482c-968c-bf4b3a3dd818

Reimbursement SL 507d4bf4-138a-4c7a-95a4-475a03d9bf0d for PackagedProductDefinition fee2773d-ed1e-45b9-8723-b6661f7bf0d5

Telmisartanum


Marketing Authorisation 54780 for MedicinalProductDefinition 285c4aa4-161e-4e78-972f-da39c5e11eed

Micardis Tabl 80 mg 28 Stk

Micardis Tabl 80 mg 98 Stk

Marketing Authorisation 54780079-7ca7738a-359a-4973-9c6b-3373548a14c7 for PackagedProductDefinition 7ca7738a-359a-4973-9c6b-3373548a14c7

Marketing Authorisation 54780095-12bcfad6-a239-436e-ba8d-2fea4991bb71 for PackagedProductDefinition 12bcfad6-a239-436e-ba8d-2fea4991bb71

Reimbursement SL db92ef85-b44d-48c5-8591-49c5a62b3fb1 for PackagedProductDefinition 7ca7738a-359a-4973-9c6b-3373548a14c7

Reimbursement SL fb4c975d-7cdb-43f5-85f0-b4224bce3a38 for PackagedProductDefinition 12bcfad6-a239-436e-ba8d-2fea4991bb71

Telmisartanum


02.07.20. Kombinierte blutdrucksenkende Mittel

Marketing Authorisation 61270 for MedicinalProductDefinition a5de9897-ce99-40a7-9ba9-1ce513f6ea6b

Micardis Amlo Tabl 40/5mg 28 Stk

Micardis Amlo Tabl 40/5mg 98 Stk

Marketing Authorisation 61270002-d425b5ce-4830-424d-8d44-a62e08a838ff for PackagedProductDefinition d425b5ce-4830-424d-8d44-a62e08a838ff

Reimbursement SL fe288361-6344-4e8d-8a7b-449e3463cddf for PackagedProductDefinition 569a5f88-3866-4998-b93c-5a60ee301989

Reimbursement SL 44f7f560-1152-4766-a7c9-f622c10714e3 for PackagedProductDefinition d425b5ce-4830-424d-8d44-a62e08a838ff

Telmisartanum

Amlodipinum


Marketing Authorisation 61270 for MedicinalProductDefinition f43b8a65-0b59-4905-9dd8-40f90909efe8

Micardis Amlo Tabl 80/5 mg 28 Stk

Micardis Amlo Tabl 80/5 mg 98 Stk

Marketing Authorisation 61270005-0b27e420-898b-4404-926d-911faa45ccca for PackagedProductDefinition 0b27e420-898b-4404-926d-911faa45ccca

Marketing Authorisation 61270006-2636fb2a-a66f-457d-af34-1d497c107ed3 for PackagedProductDefinition 2636fb2a-a66f-457d-af34-1d497c107ed3

Reimbursement SL 3d384dd6-317e-47e3-846f-dd7f67ed124f for PackagedProductDefinition 0b27e420-898b-4404-926d-911faa45ccca

Reimbursement SL b1d3aee7-be29-4ff6-a36c-0b044d61fbae for PackagedProductDefinition 2636fb2a-a66f-457d-af34-1d497c107ed3

Telmisartanum

Amlodipinum


Marketing Authorisation 61270 for MedicinalProductDefinition 4c0296be-7068-43bc-9729-9160172e9dad

Micardis Amlo Tabl 80/10 mg 28 Stk

Micardis Amlo Tabl 80/10 mg 98 Stk

Marketing Authorisation 61270007-68aaaa18-26d5-4da1-9b4c-f12fe9134dd0 for PackagedProductDefinition 68aaaa18-26d5-4da1-9b4c-f12fe9134dd0

Marketing Authorisation 61270008-766404bd-afc6-4c4e-8924-4938e34b3362 for PackagedProductDefinition 766404bd-afc6-4c4e-8924-4938e34b3362

Reimbursement SL 15534a18-f0e3-461f-aeb3-ab155e37c392 for PackagedProductDefinition 68aaaa18-26d5-4da1-9b4c-f12fe9134dd0

Reimbursement SL 5f551de2-9cd8-404a-bfbd-ff0af866aac4 for PackagedProductDefinition 766404bd-afc6-4c4e-8924-4938e34b3362

Telmisartanum

Amlodipinum


Marketing Authorisation 55970 for MedicinalProductDefinition b20ab8e4-d1b7-40e0-bd45-1cf0895d18f8

MicardisPlus Tabl 80/12.5 mg 28 Stk

MicardisPlus Tabl 80/12.5 mg 98 Stk

Marketing Authorisation 55970005-9f5e459e-1bf9-4d8a-b9d2-25240b57ab3d for PackagedProductDefinition 9f5e459e-1bf9-4d8a-b9d2-25240b57ab3d

Marketing Authorisation 55970007-92b76b9c-b1af-44ac-9ddc-4fcd8a09f86b for PackagedProductDefinition 92b76b9c-b1af-44ac-9ddc-4fcd8a09f86b

Reimbursement SL f0a50605-4e78-4693-be41-a0761817dd16 for PackagedProductDefinition 9f5e459e-1bf9-4d8a-b9d2-25240b57ab3d

Reimbursement SL 23f037a6-7b19-42c3-a0b2-dd6795f66c6b for PackagedProductDefinition 92b76b9c-b1af-44ac-9ddc-4fcd8a09f86b

Telmisartanum

Hydrochlorothiazidum


Marketing Authorisation 55970 for MedicinalProductDefinition edb95fb6-14ca-4457-a82d-9e7d11ebb814

MicardisPlus Tabl 80/25 mg 28 Stk

MicardisPlus Tabl 80/25 mg 98 Stk

Marketing Authorisation 55970009-483ef967-89a2-43e9-a009-0fb691c82b3a for PackagedProductDefinition 483ef967-89a2-43e9-a009-0fb691c82b3a

Marketing Authorisation 55970011-0896f2c8-b5ab-42cc-9348-ec3d4449a530 for PackagedProductDefinition 0896f2c8-b5ab-42cc-9348-ec3d4449a530

Reimbursement SL 53b1323c-2e48-4785-bd0f-3e67e067e259 for PackagedProductDefinition 483ef967-89a2-43e9-a009-0fb691c82b3a

Reimbursement SL 5dbc4c69-90b0-4eac-bc05-b6113bc0b22d for PackagedProductDefinition 0896f2c8-b5ab-42cc-9348-ec3d4449a530

Telmisartanum

Hydrochlorothiazidum


Marketing Authorisation 29869 for MedicinalProductDefinition 0fd625e7-8ec5-4966-a63b-a480ec3dd9d3

JNTL Consumer Health II (Switzerland) GmbH

Microlax Klist 4 Tb 5 ml

Microlax Klist 12 Tb 5 ml

Microlax Klist 50 Tb 5 ml

Marketing Authorisation 29869059-dbf0e126-da61-474f-ac5b-32dcf33b3278 for PackagedProductDefinition dbf0e126-da61-474f-ac5b-32dcf33b3278

Marketing Authorisation 29869058-01b93203-3bb4-4a7f-952c-cb6c16c68075 for PackagedProductDefinition 01b93203-3bb4-4a7f-952c-cb6c16c68075

Marketing Authorisation 29869060-9ea959bc-969a-43bc-8d77-e58890d274a5 for PackagedProductDefinition 9ea959bc-969a-43bc-8d77-e58890d274a5

Reimbursement SL 3da28b62-6e34-4a33-a69d-3b7344437def for PackagedProductDefinition dbf0e126-da61-474f-ac5b-32dcf33b3278

Reimbursement SL ea9443b4-9ef4-4238-b01a-44786b23aecb for PackagedProductDefinition 01b93203-3bb4-4a7f-952c-cb6c16c68075

Reimbursement SL f65a673a-dc13-498f-895d-80df6b79ddd3 for PackagedProductDefinition 9ea959bc-969a-43bc-8d77-e58890d274a5

Natrii citras dihydricus

Sorbitolum

Eine Grosspackung entspricht einer Packung zu 12 x 5 ml. Eine Kleinpackung entspricht einer Packung zu 4 x 5 ml. Die Gesamtmenge der Packung zu 50 x 5 ml darf nicht direkt an eine versicherte Person abgegeben werden. Es wird lediglich die abgegebene Teilpackung, die zur Therapie notwendig ist, vergütet. Der Preis für die verabreichte Teilpackung ist proportional zum Publikumspreis der verwendeten Packung zu berechnen. Die abgegebene Teilmenge darf die maximale Gesamtabgabemenge gemäss der IT-spezifischen Limitierung (IT-Code 04.08.) nicht überschreiten.


Marketing Authorisation 30241 for MedicinalProductDefinition 54ad40b4-05df-46d5-a894-833fb32e166b

Micropaque Susp 500 ml

Marketing Authorisation 30241041-982c973b-a2fe-4b16-8e1c-dd40a90ef731 for PackagedProductDefinition 982c973b-a2fe-4b16-8e1c-dd40a90ef731

Reimbursement SL 792b76ed-94e0-45a0-988b-4ce07064312e for PackagedProductDefinition 982c973b-a2fe-4b16-8e1c-dd40a90ef731

Barii sulfas


Marketing Authorisation 50151 for MedicinalProductDefinition 68468680-18b5-40a7-95c9-971d9d7efea1

Micropaque Scanner Susp 150 ml

Marketing Authorisation 50151018-91eadbdc-df46-4981-99cf-2f2d05cc2afb for PackagedProductDefinition 91eadbdc-df46-4981-99cf-2f2d05cc2afb

Reimbursement SL 79a67e5d-f1de-4dc9-ba41-3019ef979297 for PackagedProductDefinition 91eadbdc-df46-4981-99cf-2f2d05cc2afb

Barii sulfas


05.02. Mittel gegen Erkrankungen der Harnwege

Marketing Authorisation 67587 for MedicinalProductDefinition 1d724aef-c2e3-45ed-bc00-a751a7d19db2

Mictonet Drag 5 mg Blist 28 Stk

Mictonet Drag 5 mg Blist 56 Stk

Marketing Authorisation 67587002-9064a23f-b1fd-4f4d-92c0-638fab8afa65 for PackagedProductDefinition 9064a23f-b1fd-4f4d-92c0-638fab8afa65

Marketing Authorisation 67587003-cd9076e9-d8f7-44c7-913f-4dd490be0707 for PackagedProductDefinition cd9076e9-d8f7-44c7-913f-4dd490be0707

Reimbursement SL ab3bf727-e93d-4b43-90f3-0bc90e15f018 for PackagedProductDefinition 9064a23f-b1fd-4f4d-92c0-638fab8afa65

Reimbursement SL 3a4060d3-80f2-4e27-bff9-e704fa1be1ae for PackagedProductDefinition cd9076e9-d8f7-44c7-913f-4dd490be0707

Propiverinum hydrochloridum

MICTONET wird nur bei Kindern mit einem Körpergewicht von unter 35 kg vergütet.


Marketing Authorisation 67514 for MedicinalProductDefinition 47b48ef2-94b3-4a4d-8bcc-ac41af063057

Mictonorm Ret Kaps 30 mg Blist 28 Stk

Mictonorm Ret Kaps 30 mg Blist 84 Stk

Marketing Authorisation 67514002-82ff59d1-72d6-46af-a3ba-81b784841a58 for PackagedProductDefinition 82ff59d1-72d6-46af-a3ba-81b784841a58

Marketing Authorisation 67514003-3b921ebd-3f7d-4ce4-9ea8-6cb1254e1154 for PackagedProductDefinition 3b921ebd-3f7d-4ce4-9ea8-6cb1254e1154

Reimbursement SL 9dbbe690-eb18-4c80-ba4e-df4d677938f1 for PackagedProductDefinition 82ff59d1-72d6-46af-a3ba-81b784841a58

Reimbursement SL f78b5b05-2c85-4bba-aa84-c8e7f5972fcd for PackagedProductDefinition 3b921ebd-3f7d-4ce4-9ea8-6cb1254e1154

Propiverinum hydrochloridum


Marketing Authorisation 68269 for MedicinalProductDefinition 26983381-816f-4dd7-8892-23a3379ee11b

Mictonorm 45 mg Ret Kaps 45 mg Blist 28 Stk

Mictonorm 45 mg Ret Kaps 45 mg Blist 84 Stk

Marketing Authorisation 68269002-9fecf0bb-7443-423d-a487-dc678a153b47 for PackagedProductDefinition 9fecf0bb-7443-423d-a487-dc678a153b47

Marketing Authorisation 68269003-202c93c3-c1c7-4e64-bbdd-e245982497ad for PackagedProductDefinition 202c93c3-c1c7-4e64-bbdd-e245982497ad

Reimbursement SL 3865a820-d3b0-45b4-8c90-1dd7625dfe39 for PackagedProductDefinition 9fecf0bb-7443-423d-a487-dc678a153b47

Reimbursement SL db19615c-6450-4bf4-8f37-6777cb9220e0 for PackagedProductDefinition 202c93c3-c1c7-4e64-bbdd-e245982497ad

Propiverinum hydrochloridum

MICTONORM wird vergütet zur symptomatischen Behandlung von Harninkontinenz und/oder erhöhter Miktionsfrequenz und imperativem Harndrang bei Patienten mit überaktiver Blase.


Marketing Authorisation 55205 for MedicinalProductDefinition a9371894-baba-4096-a554-887d5525aff9

Mifegyne Tabl 200 mg 3 Stk

Marketing Authorisation 55205002-fa9e52e9-4957-479e-b04d-63f86e5379b0 for PackagedProductDefinition fa9e52e9-4957-479e-b04d-63f86e5379b0

Reimbursement SL 62e3e39f-f89f-44b6-9103-a01071912fc0 for PackagedProductDefinition fa9e52e9-4957-479e-b04d-63f86e5379b0

Mifepristonum


Marketing Authorisation 55205 for MedicinalProductDefinition 688d925c-ce1e-4a83-99f6-cb2d30f34433

Mifegyne Tabl 600 mg 1 Stk

Marketing Authorisation 55205001-8d720029-3c4e-4ded-bd14-63a807fc7ff4 for PackagedProductDefinition 8d720029-3c4e-4ded-bd14-63a807fc7ff4

Reimbursement SL 9ccd0d90-1325-43f8-b144-f3e702a38a2b for PackagedProductDefinition 8d720029-3c4e-4ded-bd14-63a807fc7ff4

Mifepristonum


Marketing Authorisation 67633 for MedicinalProductDefinition 50ec5195-855b-410f-8408-bab196139a64

Miglustat Dipharma Kaps 100 mg Blist 84 Stk

Marketing Authorisation 67633002-0dba24b5-c182-404d-8df2-26985fba3bfc for PackagedProductDefinition 0dba24b5-c182-404d-8df2-26985fba3bfc

Reimbursement SL b320efa7-0a3f-4e54-afc1-af3783d3892c for PackagedProductDefinition 0dba24b5-c182-404d-8df2-26985fba3bfc

Miglustatum

Zur Behandlung von erwachsenen Patienten mit leichter bis mittelschwerer Form des Morbus Gaucher Typ 1, für welche eine Enzymsubstitutionstherapie nicht möglich ist.


07.01.10. Ernährungsstörungen im Säuglingsalter

Marketing Authorisation 811dbbe6-3d83-4dd8-b6af-0aa8f0d003cf for MedicinalProductDefinition 9a2e8262-6f49-4b2f-a516-b3289d58a39b

Milupa Aptamil Pepti Syneo Plv Ds 400 g

Marketing Authorisation ab489609-8209-408e-9858-6ff51538d4f9 for PackagedProductDefinition 78d3c185-24fd-4c2d-9772-4fead23e94d5

Reimbursement SL 73eb381d-26d1-4dd8-915c-3c687e87a0c5 for PackagedProductDefinition 78d3c185-24fd-4c2d-9772-4fead23e94d5

Materia crassa

Carbohydrata

Fibrae alimentariae

Proteina

Vitamina

Mineralia

Spurenelemente

Die aufgeführten Präparate dürfen nur für Säuglinge bis zu 12 Monaten verordnet werden.

Kostenübernahme für 6 Monate bei Säuglingen mit Kuhmilchproteinintoleranz. In begründeten Fällen und nach Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes Verlängerung für 3 bis maximal 6 Monate.


Marketing Authorisation 3387075f-89d9-4dff-bfbe-431228354156 for MedicinalProductDefinition 20b93543-b0b5-46dd-adcd-b6ac084374cb

Milupa Aptamil Pregomin Plv Ds 400 g

Marketing Authorisation 7510e7f6-44b5-4b2a-9b57-add05153dbd1 for PackagedProductDefinition c3260463-7501-45e6-a75c-d700e121f35a

Reimbursement SL 342a1cea-39cf-4dc6-9b16-334e637e3269 for PackagedProductDefinition c3260463-7501-45e6-a75c-d700e121f35a

Materia crassa

Carbohydrata

Proteina

Vitamina

Mineralia

Spurenelemente


Marketing Authorisation 20d80b81-0a94-4951-bd45-de1852b064f0 for MedicinalProductDefinition b1747ee6-14b2-46b2-aae2-7e59d911e855

Milupa Aptamil Pregomin AS Plv 400 g (neu)

Marketing Authorisation 10941127-6673-4f57-8d02-878e8c6b6638 for PackagedProductDefinition 27d0cb0a-0bed-4d5e-ab0e-b619ed11a026

Reimbursement SL 7fb1e87a-a4a0-428d-81a9-da03ce6f191a for PackagedProductDefinition 27d0cb0a-0bed-4d5e-ab0e-b619ed11a026

Materia crassa

Carbohydrata

Proteina

Vitamina

Mineralia

Spurenelemente

Als Zweitlinientherapie bei ungenügendem Ansprechen auf extensiv hydrolysierte Säuglingsmilch, nach Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.


Marketing Authorisation 39bc0d12-0f3e-400c-8a33-47b190fc1fa3 for MedicinalProductDefinition 0c978a11-1ca5-493e-bca0-e64680ff06ce

Milupa GA 1 Bébé 500 g

Marketing Authorisation ab099f70-c7eb-4a44-b9c3-77882789ad5c for PackagedProductDefinition 19ad47c2-5067-443e-868e-99a9d8a77c44

Reimbursement SL fd77b57f-89f5-4823-bf72-f9fff0ebcc1a for PackagedProductDefinition 19ad47c2-5067-443e-868e-99a9d8a77c44


Marketing Authorisation 42fc09b0-6186-4ffb-ace2-06f1bd1b403a for MedicinalProductDefinition 76a3f11c-871b-4490-b2bc-54d9237143e0

Milupa GA 2-prima ab 1 Jahr 500 g

Marketing Authorisation 76b73c4e-6ae4-459b-a0c1-e4ffe5b2a9a0 for PackagedProductDefinition 21861dc2-0ae2-47d4-ac74-0b93fd23561d

Reimbursement SL 2b972c8c-d1b0-4f54-8733-df8c30392a56 for PackagedProductDefinition 21861dc2-0ae2-47d4-ac74-0b93fd23561d


Marketing Authorisation b6b2b19e-c22b-4418-abf7-25f40ad9c239 for MedicinalProductDefinition f81acc37-dc19-4899-8c8a-521cf64674e5

Milupa HOM 1 Bébé 500 g

Marketing Authorisation f851e520-fa6f-4c1d-af01-144a5fa6db01 for PackagedProductDefinition f08901ad-fe34-44b0-b567-d0e6bf2c8395

Reimbursement SL ab4aa278-5fdf-456d-b14b-2f11d43f2d0f for PackagedProductDefinition f08901ad-fe34-44b0-b567-d0e6bf2c8395


Marketing Authorisation fd65993f-b36b-49e4-a895-1f6c2a836c3d for MedicinalProductDefinition a6955c0b-7b40-4b51-a165-0d4d988b05b3

Milupa HOM 1 Plv Bébé 500 g

Marketing Authorisation c7ce12d1-e4d7-43ac-912d-8d5df642d6e9 for PackagedProductDefinition b4e47a03-d50c-43eb-a724-ff4e943e3ab0

Reimbursement SL 7325f13a-4f25-49f1-9122-242c65e50e07 for PackagedProductDefinition b4e47a03-d50c-43eb-a724-ff4e943e3ab0

Carbohydrata

Proteina

Vitamina

Mineralia

Spurenelemente

Aminoacida


Marketing Authorisation f076e595-8afc-43e2-91bb-ee954811beba for MedicinalProductDefinition 250dafa5-ca27-46a3-9590-f5b94e33e4cb

Milupa HOM 2-prima 1-8 Jahre 500 g

Marketing Authorisation cdc6f1b8-849a-4dd2-9b89-d7df331b6da1 for PackagedProductDefinition 21377397-592e-45b9-a9ce-e2c022451333

Reimbursement SL 1bd82195-91cb-4c44-b802-0042f47026c6 for PackagedProductDefinition 21377397-592e-45b9-a9ce-e2c022451333


Marketing Authorisation 86793443-cddd-4c99-b508-7a100fbe7232 for MedicinalProductDefinition e4c9395d-4f78-4480-a787-42ea436fd841

Milupa HOM 2-secunda 9-14 Jahre 500 g

Marketing Authorisation e4d73ed5-ee6a-4a5a-9636-95ebdc7331ad for PackagedProductDefinition b39ab255-169d-4643-b908-d54782c695c3

Reimbursement SL 78a65ea3-1a9c-4af0-ac13-bc76a19259f2 for PackagedProductDefinition b39ab255-169d-4643-b908-d54782c695c3


Marketing Authorisation 4e2f7396-ad62-4980-9c9f-397c7e0e5309 for MedicinalProductDefinition c8ff3c6c-f072-48ca-8b6a-7b7e0d83ec7f

Milupa HOM 3-advanta ab 15 Jahre 500 g

Marketing Authorisation c6f6c22f-303d-4ae1-9e6b-fca2d03b7f8e for PackagedProductDefinition 04c1b7cf-b5c1-4433-a824-e6c11747ccb8

Reimbursement SL 13f5cd32-6e1f-49fd-81f0-67327527eb1f for PackagedProductDefinition 04c1b7cf-b5c1-4433-a824-e6c11747ccb8


Marketing Authorisation 2269df85-d667-4314-8acf-46050c017fee for MedicinalProductDefinition 2e8a3689-b976-4011-b606-17550449a86e

Milupa LEU 1 Bébé 500 g

Marketing Authorisation 2460fb93-0754-41bc-acc0-742223dc6884 for PackagedProductDefinition 98d26b72-c99e-437a-912c-484378cc4087

Reimbursement SL 909e85ec-fc90-4850-a589-23854f5fb6f6 for PackagedProductDefinition 98d26b72-c99e-437a-912c-484378cc4087


Marketing Authorisation 2be3bbeb-70cf-403c-9d4e-edcd757242aa for MedicinalProductDefinition e26fa307-7e47-4788-9eb8-4e8e13805342

Milupa LEU 1 Plv Bébé 500 g

Marketing Authorisation 5523aa21-4a2d-4185-8215-acc545fb0e7e for PackagedProductDefinition 20433f34-9073-40dd-81d4-1517ad0db920

Reimbursement SL 68581bbc-d276-491d-9ce7-d8bd37ab4643 for PackagedProductDefinition 20433f34-9073-40dd-81d4-1517ad0db920


Marketing Authorisation c6389135-ffb0-4417-b4ba-ea5d48cb0ca6 for MedicinalProductDefinition 7f6ec521-abbc-477d-b770-eb84fe35f7f2

Milupa LEU 2-prima ab 1 Jahr 500 g

Marketing Authorisation e39600be-24af-41af-b417-e06a17333aed for PackagedProductDefinition 37f4c4e8-4d46-420b-92d0-0f605cd5d3eb

Reimbursement SL 81d02870-36ac-4b8d-af0e-79b33e2a560f for PackagedProductDefinition 37f4c4e8-4d46-420b-92d0-0f605cd5d3eb